University of Pennsylvania

ScholarlyCommons
Publicly Accessible Penn Dissertations
2012

Commensal Bacterial Communities Regulate Antiviral Immunity
Michael Christopher Abt
University of Pennsylvania, abtc@mail.med.upenn.edu

Follow this and additional works at: https://repository.upenn.edu/edissertations
Part of the Allergy and Immunology Commons, Immunology and Infectious Disease Commons,
Medical Immunology Commons, and the Microbiology Commons

Recommended Citation
Abt, Michael Christopher, "Commensal Bacterial Communities Regulate Antiviral Immunity" (2012).
Publicly Accessible Penn Dissertations. 485.
https://repository.upenn.edu/edissertations/485

This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/485
For more information, please contact repository@pobox.upenn.edu.

Commensal Bacterial Communities Regulate Antiviral Immunity
Abstract
Alterations in the composition of commensal bacterial communities in the human intestine are
associated with enhanced susceptibility to multiple inflammatory diseases. Further, studies in murine
model systems have demonstrated that signals derived from commensal bacteria can influence immune
cell development, function and homeostatic regulation within the intestinal environment, leading to
altered host susceptibility to infectious or inflammatory diseases. However, whether commensal bacteriaderived signals regulate protective immunity to viral pathogens that infect sites outside of the
gastrointestinal microenvironment remain poorly understood. Chapter 2 of this thesis examines this
question and demonstrates that disruption or absence of commensal bacterial communities results in
impaired protective immunity to respiratory influenza virus. Antibiotic (ABX)-mediated disruption of
intestinal commensal bacteria significantly impaired the innate and adaptive immune response,
abrogated viral clearance and increased host mortality following influenza virus infection indicating a
crucial role for commensal bacterial communities in regulating antiviral immune defense. Chapter 3
interrogates the influence of commensal bacteria-derived signals on the antiviral immune response to
systemic viral infection. Following infection with Lymphocytic Choriomeningitis virus (LCMV), ABX-treated
mice exhibited functionally impaired LCMV-specific CD4 and CD8 T cell responses that correlated with
significantly delayed viral clearance. Collectively, Chapters 2 and 3 indicate a global role for commensal
bacteria-derived signals in regulating immunity to mucosal or systemic viral infection. Chapter 4
examines the mechanisms underlying commensal bacteria regulation of antiviral immunity and identifies
a previously unrecognized role for commensal bacteria-derived signals in establishing the activation
threshold of the innate immune system. Genome-wide transcriptional profiling of macrophages isolated
from ABX-treated mice revealed decreased expression of genes associated with antiviral immunity.
Moreover, macrophages isolated from ABX-treated mice prior to viral infection exhibited defective
responses to type I/II IFNs and a reduced capacity to limit viral replication. Strikingly, adoptive transfer of
macrophages from CNV mice into ABX-treated mice prior to LCMV infection resulted in significantly
improved virus-specific adaptive immune responses and effectively restored the ability of ABX-treated
mice to control viremia. Taken together, the results presented in this thesis indicate that commensal
bacteria-derived signals calibrate the activation threshold of the innate immune system, providing tonic
immune stimulation essential for optimal antiviral immunity.
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ABSTRACT
COMMENSAL BACTERIAL COMMUNITIES REGULATE ANTIVIRAL IMMUNITY

Michael Christopher Abt

David Artis, PhD
Alterations in the composition of commensal bacterial communities in the human
intestine are associated with enhanced susceptibility to multiple inflammatory diseases.
Further, studies in murine model systems have demonstrated that signals derived from
commensal bacteria can influence immune cell development, function and homeostatic
regulation within the intestinal environment, leading to altered host susceptibility to
infectious or inflammatory diseases. However, whether commensal bacteria-derived
signals regulate protective immunity to viral pathogens that infect sites outside of the
gastrointestinal microenvironment remain poorly understood. Chapter 2 of this thesis
examines this question and demonstrates that disruption or absence of commensal
bacterial communities results in impaired protective immunity to respiratory influenza
virus. Antibiotic (ABX)-mediated disruption of intestinal commensal bacteria significantly
impaired the innate and adaptive immune response, abrogated viral clearance and
increased host mortality following influenza virus infection indicating a crucial role for
commensal bacterial communities in regulating antiviral immune defense. Chapter 3
interrogates the influence of commensal bacteria-derived signals on the antiviral immune
response

to

systemic

viral

infection.

Following

infection

with

Lymphocytic

Choriomeningitis virus (LCMV), ABX-treated mice exhibited functionally impaired LCMVspecific CD4 and CD8 T cell responses that correlated with significantly delayed viral
v

clearance. Collectively, Chapters 2 and 3 indicate a global role for commensal bacteriaderived signals in regulating immunity to mucosal or systemic viral infection. Chapter 4
examines the mechanisms underlying commensal bacteria regulation of antiviral
immunity and identifies a previously unrecognized role for commensal bacteria-derived
signals in establishing the activation threshold of the innate immune system. Genomewide transcriptional profiling of macrophages isolated from ABX-treated mice revealed
decreased expression of genes associated with antiviral immunity. Moreover,
macrophages isolated from ABX-treated mice prior to viral infection exhibited defective
responses to type I/II IFNs and a reduced capacity to limit viral replication. Strikingly,
adoptive transfer of macrophages from CNV mice into ABX-treated mice prior to LCMV
infection resulted in significantly improved virus-specific adaptive immune responses and
effectively restored the ability of ABX-treated mice to control viremia. Taken together, the
results presented in this thesis indicate that commensal bacteria-derived signals
calibrate the activation threshold of the innate immune system, providing tonic immune
stimulation essential for optimal antiviral immunity.
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Chapter 1
Introduction
1.1 Commensal bacterial communities in health and disease
All mammals are born sterile, but colonization with beneficial microbial species begins
soon after birth (Dethlefsen et al., 2007; Ley et al., 2006a). Commensal microbial
communities colonize host organisms at multiple barrier surfaces including the skin,
mouth, nasopharynx, vaginal, and gastrointestinal tract, and establish a symbiotic
relationship with the host organism. (Clemente et al., 2012; Ley et al., 2006a; Round and
Mazmanian, 2009). These microorganisms have an important role in host nutrition by
breaking down food by-products and producing essential vitamins. Commensal microbes
also have a passive role in host defense by competing with other potentially pathogenic
organisms for space and resources in the gut microenvironment (Hooper and Gordon,
2001; Smith et al., 2007). Dysbiosis of commensal microbial communities, however, is
associated with various disease states such as obesity (Turnbaugh et al., 2006),
inflammatory bowl disease (Ott et al., 2004), and atopic disorders (Marra et al., 2009).
These clinical observations highlight the need to better understand how commensal
microbial communities shape human health and susceptibility to disease.
1.1.1 Composition of intestinal commensal bacterial communities
Intestinal commensal microbial communities are comprised of bacteria, fungi, protozoa,
and viruses that inhabit the gastrointestinal tract (Breitbart et al., 2003; Ley et al., 2006a;
Scupham et al., 2006). The bacterial component of these microbial communities is the
most well defined and studied. A large degree of diversity of bacterial species is found
throughout the intestine with the lowest total concentration of microbes found in the
1

duodenum and steadily increasing until the peak density of 1011 -1012 colony forming
units (CFU) /mL of luminal content in the proximal large intestine (Marteau et al., 2001;
Savage, 1977). Culture-based identification of the bacterial species residing in the
human intestine have identified members of the Lactobacilli, Streptococci and
Bacteroides genera, however, these techniques are limited because the majority of
commensal bacterial species do not grow using current laboratory techniques
(Adlerberth and Wold, 2009; Dubos et al., 1965). Use of high-throughput sequencing
technology has expanded the ability to identify both culturable and non-culturable
bacterial species residing in the human intestine and current estimates of total diversity
range between 15,000 and 36,000 species (Frank et al., 2007). The majority of these
bacteria belong to the Bacteroidetes (~68%) and Firmicutes (~31%) phyla, with smaller
percentages from the Proteobacteria, Actinobacteria, Deferribacteres, and Tenericutes
phyla (Figure 1) (Eckburg et al., 2005; Hayashi et al., 2002; Wang et al., 2003). Intestinal
commensal bacteria exhibit spatial diversity along the intestinal tract with some classes
of bacteria preferentially residing either in the lumen or the mucus that coats the apical
surface of intestinal epithelial cells (Hill and Artis, 2010). Due to proximity, mucosalassociated bacteria are more likely to interact with host cells. Therefore, the location of
colonization is likely to be equally, or more important in influencing intestinal
homeostasis as total quantity of particular bacterial species.
1.1.2 Commensal bacterial communities and human disease
Alterations in the composition of intestinal commensal bacterial communities have been
linked with several human diseases. The occurrence of obesity in both mice and humans
has been associated with a decrease in the frequency of Bacteroidetes and an increase
among Firmicutes (Turnbaugh et al., 2006). The shift in the Bacteroidetes/Firmicutes
2

ratio increases the ability of the commensal bacteria to break down indigestible fiber into
short-chain fatty acids (SCFA), thus providing an additional energy source that is
capable of being converted into fat. (Ley et al., 2006b; Schwiertz et al., 2008). In addition
to obesity, clinical evidence has linked commensal bacteria to the unregulated immune
responses observed in inflammatory bowel diseases (IBD) such as Crohn’s disease (De
Hertogh et al., 2006; Dicksved et al., 2008), ulcerative colitis (Rutgeerts et al., 2005),
and coeliac disease (Tlaskalova-Hogenova et al., 2004), as well as colon cancer (Karin
et al., 2006; Moore and Moore, 1995). Clinical investigations into the etiology of intestinal
inflammatory disease has revealed decreased species diversity within the patients’
intestinal commensal bacterial community (Ott et al., 2004) and aberrant immune
responses such as IgG antibody production (Macpherson et al., 1996), T cell activation
(Duchmann et al., 1995), and proinflammatory cytokine secretion (Medina et al., 2008) in
response to bacteria found within the intestine. Furthermore, deliberate manipulation of
commensal bacterial using antibiotics or diversion of the fecal stream away from the
inflamed portion of the intestine has been moderately successful in treating Crohn’s
disease, thus strengthening the link between commensal bacterial communities and
intestinal inflammation (Casellas et al., 1998; D'Haens et al., 1998; Rutgeerts et al.,
1991; Sartor, 2004).
Perturbations of commensal bacterial communities have also been linked to other
dysregulated inflammatory diseases at sites outside of the intestine, such as asthma and
other atopic disorders (Penders et al., 2007a). In particular, there is a strong correlation
between treating infants with multiple rounds of antibiotics and the development of
asthma (Kozyrskyj et al., 2007; Marra et al., 2009). The presence of particular bacterial
species in the intestine, such as Bifidobacterium pseudocatenulatum, Clostridium
3

difficile, and Escherichia coli are also associated with increased cases of eczema (Gore
et al., 2008; Penders et al., 2007b). Because of the correlation between altered
commensal bacterial communities and inflammatory diseases, administration of
“probiotic” bacterial species has been employed to prevent or ameliorate certain atopic
and intestinal inflammatory diseases (Gionchetti et al., 2000; Hart et al., 2003; Hedin et
al., 2007; Kukkonen et al., 2007; Mimura et al., 2004). Despite encouraging results, the
full potential of probiotic therapy may not be realized until the mechanisms by which
commensal bacterial communities shape the immune responses that drive these
inflammatory diseases are understood.

1.2 Commensal bacterial communities and the immune system
Associations between commensal bacterial communities and human inflammatory
diseases have implicated commensal bacteria-derived signals in shaping the immune
responses that drive pathogenesis. Studies using murine model systems demonstrate
that manipulation of commensal bacteria can alter mammalian immune cell homeostasis
and specific commensal bacteria-derived signals have been identified that can impact
immune cell function both within the intestinal tract and in peripheral tissues (Littman and
Pamer, 2011; Macpherson and Harris, 2004). These commensal bacteria-derived
signals can either have an immunoregulatory effect, creating a state that is refractory to
inflammation, or conversely, act as an adjuvant, aiding in the propagation of an immune
response. Innate immune cells responding to commensal bacterial-derived signaling can
modulate both the local and systemic immune response (Honda and Littman, 2012;
Littman and Pamer, 2011; Round and Mazmanian, 2009). This section will discuss the
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mechanisms through which commensal bacterial communities shape the host immune
system.
1.2.1 Impact of commensal bacterial communities on immune system
development and homeostasis
The commensal bacterial communities of the mammalian gastrointestinal tract are
integral in shaping the development and function of the immune system. Mouse models
enable the manipulation of the commensal bacterial communities and systematic
investigation of how commensal bacteria influence immune responses of the host.
Studies employing mice lacking bacterial communities (germ-free) demonstrate the need
for commensal bacteria-derived signals in the development of gut-associated lymphoid
tissues (GALT). Germ-free (GF) mice have fewer Peyer’s patches along the small
intestine and the mesenteric lymph nodes of these mice have decreased cellularity
(Smith et al., 2007). Further, commensal bacteria-derived signals have been shown to
stimulate intestinal epithelial cells (IECs) to stimulate production of cytokines that foster
lymphoid tissue genesis (Bouskra et al., 2008). Defective development of lymphoid
architecture is not limited to the GALT as the spleen of GF mice lack germinal centers
and have poorly formed T and B cell zones (Macpherson and Harris, 2004).
Loss of commensal bacteria signaling alters the distribution, activation level,
differentiation status, and inflammatory profile of dendritic cells, macrophages, NK cells,
B cells, CD4 and CD8 T cells, both within the GALT and at distal sites within the host
(Hill and Artis, 2010; Macpherson and Harris, 2004). GF mice exhibited fewer intestinal
dendritic cells (DCs) (Williams et al., 2006), intraepithelial lymphocytes (Smith et al.,
2007), lamina propria CD4+ T cells (Macpherson and Harris, 2004), and IgA+ B cells
5

(Macpherson et al., 2001). These inherent developmental defects in GF mice make it
challenging to parse out the cause of altered immune cell function and have been the
motivating factor to develop complementary methods to study the impact of commensal
bacterial communities on immune cell function at steady-state.
Manipulation of commensal bacterial communities in mice reared in a conventional
environment via antibiotic (ABX) treatment has demonstrated that commensal bacteria
influence intestinal immune cell homeostasis even after the developmental stage. An
example that illustrates this paradigm of interactions between commensal bacteria and
immune cell populations is the role commensal bacteria have in influencing CD4 T cell
differentiation in the intestinal lamina propria. GF mice exhibit fewer CD4 T helper 17
(TH17) cells in the lamina propria of the small intestine compared to conventionally
reared (CNV) mice (Atarashi et al., 2008; Niess et al., 2008). In addition to GF studies,
selective depletion of commensal bacterial communities by oral administration with a
specific antibiotic (vancomycin) also results in reduced percentage of TH17 cells in the
lamina propria of the small intestine (Ivanov et al., 2008). The commensal bacteria,
Segmented Filamentous Bacteria (SFB), were identified to be the driving factor in
promoting the development of CD4 TH17 cells. The mechanisms through which SFB
promotes of CD4 TH17 cell differentiation is believed to involve conditioning of DCs by
Serum amyloid A, which promote differentiation into a RORγt+ TH17 lineage in CD4 T
cells (Ivanov et al., 2009). As will be discussed in further detail later in Section 1.2.5, the
induction of CD4 TH 17 cells by SFB has significant physiological consequences in
immune homeostasis. While SFB can promote CD4 TH17 cell differentiation, another
class of commensal bacteria, Clostridia, promotes CD4 T cells in the intestine to a T
regulatory cell fate (Atarashi et al., 2011). These observations emphasize that signals
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from distinct bacterial species can have a differential role in influencing the immune cell
development within the intestine.
Use of the GF mouse system has been critical in demonstrating a role for bacteria in
the induction and propagation of intestinal inflammation. Production of inflammatory
cytokines in the intestine is a hallmark characteristic of IBD and is believed to be driven
by commensal bacteria stimulation (Duchmann et al., 1995; Fiocchi, 1998; Frank et al.,
2007; Kaser et al., 2010). Several transgenic mouse strains that are defective in
immunoregulatory mechanisms, such as IL-10 production (Kuhn et al., 1993) or
regulatory T cell development (Sadlack et al., 1993) spontaneously produce
inflammatory cytokines in the intestine and develop intestinal inflammation. When rederived into a sterile, germ-free environment, however, these mouse strains no longer
exhibit spontaneous disease, supporting the link between commensal bacteria and
intestinal inflammation (Dianda et al., 1997; Schultz et al., 1999; Sellon et al., 1998).
Furthermore, it has been demonstrated that transfer of colitis-inducing bacterial species
from a genetically susceptible host into wild type recipients can initiate disease (Elinav et
al., 2011; Garrett et al., 2010a; Garrett et al., 2007). Thus certain bacterial species are
capable of inducing intestinal inflammation in otherwise healthy hosts. Conversely,
probiotic bacterial species can ameliorate intestinal inflammation and disease (Dieleman
et al., 2003; Round and Mazmanian, 2010). These divergent effects of commensal
bacterial species on intestinal homeostasis highlight the need to understanding how
commensal bacteria are detected by intestinal immune and non-immune cell
populations.
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1.2.2 Recognition of commensal bacteria-derived signals in the intestine
The immune system within the GALT must be able to initiate an appropriate immune
response against invading pathogens yet remain hypo-responsive to bacterial signals
from the commensal bacteria. The resulting balance between proinflammatory and
immunoregulatory signals is thought to be dependent on the context in which the
bacterial signals are recognized. DCs are a key cell type that modulates the immune
response within the intestine (Coombes and Powrie, 2008; Jaensson et al., 2008; Sun et
al., 2007). DCs within the intestine are exposed to bacterial products via M cell antigen
sampling within Peyer’s patches or directly by extending dendrites between tight
junctions of IECs and into the intestinal lumen (Mach et al., 2005; Milling et al., 2005;
Niess et al., 2005; Rescigno et al., 2001). Intestinal DCs are capable of phagocytizing
live bacteria then migrating into the mesenteric lymph nodes to present commensal
bacteria antigen to resident T and B cells (Macpherson and Uhr, 2004). This process is
thought to be important in driving production of commensal bacteria specific IgA. DCs
express a wide range of pattern recognition receptors (PRRs) that can be activated by
microbial products. PRRs expressed by DCs include members of the transmembrane
toll-like receptor (TLR) family and the intracellularly residing nucleotide-binding
oligomerization domain (NOD) like receptors (NLRs) (Iwasaki and Medzhitov, 2004;
Medzhitov, 2007). Pathogen-associated molecular patterns (PAMPs) directly stimulate
TLRs or NLRs leading to activation of the conserved Nuclear factor kappa B (NFκB),
mitogen-activating pathway kinase (MAPK), and inflammasome signaling pathways
resulting in the expression of a proinflammatory gene profile characterized by cytokines
such as IL-12, IL-1β, and type I interferons (Akira and Takeda, 2004; Franchi et al.,
2009; Girardin et al., 2003a; Girardin et al., 2003b; Strober et al., 2006). However, not all
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DC/PAMP interactions in the intestine result in proinflammatory immune responses.
Stimulation of intestinal DCs with the TLR4 ligand, lipopolysacchride (LPS), does not
result in costimulatory molecule upregulation or IL-12p70 expression as is normally seen
with DCs derived from other tissues of the body. Instead, LPS stimulation results in
elevated IL-10 production by intestinal DCs (Cerovic et al., 2009; Monteleone et al.,
2008; Takenaka et al., 2007). In addition, NOD2 signaling has been shown to negatively
regulate TLR2 activation of the NFκB pathway and thereby attenuate expression of TH1
associated cytokines IL-12, and IFN-γ (Watanabe et al., 2004; Yang et al., 2007).
The intestinal epithelium maintains a physical barrier between the commensal bacteria
of the intestinal environment and the host. Located at this host/bacteria interface, IECs
experience constant, direct exposure from commensal bacterial communities and are
therefore in a position to sense and respond to commensal bacteria. IECs can express
TLRs and NOD receptors that sense bacterial stimuli (Fritz et al., 2006; Hisamatsu et al.,
2003; Medzhitov, 2007), though the anatomical location of these PRRs may be an
important factor in determining responsiveness of IECs to bacterial stimulation. For
example, TLR5, which recognizes bacterial flagellin, is only expressed on the basolateral
surface of IECs, and therefore sequestered from bacterial contact on the apical surface
of the cell (Gewirtz et al., 2001). Other cell membrane-associated PRRs, such as TLR2
and 4 are expressed at low or undetectable levels in IECs (Abreu et al., 2001; Melmed et
al., 2003) while endosomally or cytosolically located PRRs, such as TLR3,7,8,9 and
NOD protein are expressed at higher levels in IECs (Medzhitov, 2007). Commensal
bacteria-derived signaling in IECs via these PRRs influence intestinal immune cell
development and are critical in maintaining homeostasis (Bouskra et al., 2008;
Hasegawa et al., 2006; Nenci et al., 2007; Rakoff-Nahoum et al., 2004; Zaph et al.,
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2007). Commensal bacteria-derived signals acting upon IECs can induce an
immunoregulatory environment characterized by cytokines such as IL-10, TGF-β, TSLP,
and IL-25, which modulate DC, macrophage, T and B cell activation (Figure 2) (Dignass
and Podolsky, 1993; He et al., 2007; Rimoldi et al., 2005a; Taylor et al., 2009; Zeuthen
et al., 2008). Similar to DCs, PRR activation in IECs by invading pathogens can also
elicit a proinflammatory response that is important in initiating the intestinal immune
response to infection (Zilbauer et al., 2007). Thus IECs exhibits a PRR expression profile
that limits continuous proinflammatory stimulation, but is poised to respond to invasive
pathogens upon breakdown of the epithelial barrier. Therefore, while cells within the
intestinal compartment express TLR and NOD receptors and the ligands for these PRRs
are found within commensal bacterial communities, the outcome of PAMP/PRR
interactions is dependent upon the context in which they occur. Recent work has
elucidated several specific commensal bacteria-derived signals that can activate TLR or
NOD signaling and influence immune cell homeostasis. These can be broadly
categorized into signals that have an immunoregulatory effect or signals that promote
proinflammatory immune responses.
1.2.3 Immunoregulatory signals derived from commensal bacterial communities
Commensal bacteria appear to be integral in inducing an immunoregulatory environment
within the intestine. GF mice were reported to have reduced expression of IL-25 in the
large intestine, an immunoregulatory cytokine involved in driving type 2 immune
responses (Saenz et al., 2008; Zaph et al., 2008). Further, Clostridium species have
been reported to induce accumulation of IL-10 producing Foxp3+ CD4 regulatory T cells
in the lamina propria of the colon (Atarashi et al., 2011). Medzhitov and colleagues
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implicate the commensal bacteria-derived signals LPS or lipoteichoic acid (LTA) in
regulating intestinal immune homeostasis via TLR4 and TLR2 signaling, respectively. In
this study, mice depleted of commensal bacterial communities by antibiotics display
exacerbated intestinal inflammation and increased mortality following administration of
dextran sodium sulfate (DSS) in the drinking water, a chemically-induced colitis model
(Rakoff-Nahoum et al., 2004). However, ABX-treated mice, subsequently treated with
LPS, were able to limit intestinal inflammation and recover from chemically-induced
colitis (Rakoff-Nahoum et al., 2004). Subsequent studies have identified commensal
bacteria-mediated protection to be dependent on MyD88-mediated TLR signaling on
hematopoietic cells, particularly intestinal B cells (Kirkland et al., 2012; Rakoff-Nahoum
et al., 2006). These results indicate that commensal bacterial communities can modulate
intestinal inflammation and that a specific bacterial product can orchestrate these
immunoregulatory effects in the absence of living commensal bacteria.
Although TLR ligands have been predominantly shown to activate a proinflammatory
response, TLR activation is capable of dampening an inflammatory response under
certain conditions. A series of studies have demonstrated that signaling through TLR2 by
polysaccharide A (PSA) could induce an environment refractive to inflammation. A
unique form of PSA, specific to Bacteroides fragilis, induces an immunoregulatory
phenotype in CD4 T cells that was highlighted by elevated production of the
immunoregulatory cytokine IL-10 (Mazmanian et al., 2005; Mazmanian et al., 2008;
Wang et al., 2006). Treatment with PSA isolated from Bacteroides fragilis prevents the
induction of Helicobacter hepaticus-induced colitis, indicating that a single commensal
bacteria-derived molecule can influence the immune response within the intestinal
environment.
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In addition to TLR ligands, commensal bacteria provide other signaling molecules that
modulate the intestinal immune network and prevent pathologic inflammation. The
NOD2 ligand muramyl dipeptide (MDP), a component of bacterial peptidoglycan, was
found to negatively regulate the production of IL-12p40, IL-6 and TNF-α by DCs in vitro
(Watanabe et al., 2008). Furthermore, in vivo administration of MDP resulted in a
diminished proinflammatory cytokine profile of colonic lymphocytes and was able to
protect against trinitrobenzene sulfonic acid (TNBS) induced colitis (Watanabe et al.,
2008). Van Kooyk and colleagues described a specific surface layer A protein (SlpA)
present on the intestinal bacterial specie Lactobacillus acidophilus NCFM that enables
bacterial binding to dendritic cells resulting in the production of IL-10 and inhibition IL12p70 (Konstantinov et al., 2008).

Also, butyrate, a SCFA byproduct of intestinal

bacteria fermentation of dietary fibers (Roediger, 1980), has been shown to be a major
energy source of colonic epithelial cells and can reduce the expression of TNF-α, TNF-β,
IL-6 and IL-1β in lamina propria lymphocytes via NFκB inhibition in Crohn’s and
ulcerative colitis patients (Luhrs et al., 2002; Segain et al., 2000). SCFA, via binding and
signaling through the G-protein receptor 43 (GPR43) has been shown to limit
inflammatory response (Le Poul et al., 2003; Maslowski et al., 2009). Mice deficient in
GPR43 exhibited exacerbated intestinal inflammation following treatment with DSS.
Similarly, GF mice, which lack the bacteria to break down fiber into SCFA also exhibited
increased weight loss and rectal bleeding following DSS administration (Maslowski et al.,
2009). Treatment of these GF mice with acetate in the water to supplement SCFA
deficiency markedly diminished disease severity and proinflammatory cytokine levels in
the intestine, demonstrating that a commensal bacteria-derived metabolite could limit
inflammatory responses and disease progression (Maslowski et al., 2009). Each of these
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commensal bacteria-derived products described in this section is a potential conduit
through which the intestinal commensal bacteria can regulate the immune system.
1.2.4 Proinflammatory signals derived from commensal bacterial communities
Although signals from commensal bacterial communities can help establish an
immunoregulatory environment, there is also evidence from human and mouse studies
linking commensal bacteria to promotion of intestinal inflammatory diseases. As
described in Section 1.2.1, GF and ABX-treated mouse studies have demonstrated the
role for commensal bacteria in dictating the balance between proinflammatory TH17 and
regulatory T cells populating the GALT (Atarashi et al., 2008; Ivanov et al., 2008; Niess
et al., 2008). Takeda and colleagues attributed this capability to bacterial-derived ATP
preferentially inducing TH17 CD4+ T cells. ATP was shown to act on a population of
CD70high CD11clow accessory cells that express P2X receptors, a family of ATP-binding
receptors. ATP stimulation induced these cells to express IL-6 and IL-23p19, cytokines
that can promote TH17 cell development and survival(Atarashi et al., 2008). In addition to
ATP, several commensal bacterial species have been demonstrated to have
proinflammatory properties. Klebsiella pneumoniae and Proteus mirabilis were identified
by high-throughput sequence screening of intestinal bacterial communities from the Tbet-/- x Rag2-/- ulcerative colitis (TRUC) mouse model. These commensal bacterial
species could elicit intestinal inflammation when transferred to wild type or Rag2-/recipients (Garrett et al., 2010a). In another study, commensal bacterial species
Bacteroides vulgatus and Bacteroides thetaiotaomicron isolated from the intestine
bacterial communities of a Il10r2, Tgrbr2 double knockout mice, an IBD-susceptible
mouse strain, induced spontaneous intestinal inflammation where as Enterobacteriaceae
species identified from the same IBD-susceptible mice did not elicit onset of disease
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(Bloom et al., 2011). While these studies have identified particular bacterial species that
can elicit proinflammatory effects on the host, the specific bacterial products and
mechanism of action by which these commensal bacterial species have proinflammatory
effects remains poorly defined. This gap in knowledge highlights the need to identify
specific bacterial signals and the immune pathways that are activated by commensal
bacteria.
1.2.5 Commensal bacterial communities influence the systemic inflammatory
immune response
The effect of commensal bacterial communities on the immune system go beyond the
intestine and have been shown to influence immune responses and cell populations at
peripheral sites. For example, GF mice exhibit diminished proinflammatory cytokine
responses to subcutaneous LPS injection or ischemic perfusion (Amaral et al., 2008;
Souza et al., 2004). In addition, mice depleted of commensal bacterial communities via
ABX treatment exhibit an exacerbated, TH2 cytokine mediated, allergic response to
intranasal challenge OVA or house dust mite antigen (Hill et al., 2012; Noverr et al.,
2005). Furthermore, it was demonstrated that commensal bacterial communities were
responsible for ameliorating the severity of spontaneous diabetes in MyD88-/- NOD mice
(Wen et al., 2008). In addition, peptidoglycans derived from commensal bacteria were
demonstrated to stimulate recruitment of bone marrow-derived neutrophils to the
peritoneal cavity through the NOD1 receptor and enhance phagocytosis of bacteria
(Clarke et al., 2010). Many of the bacterial species and products identified in regulating
intestinal immune homeostasis also influence systemic immune responses to
autoimmune inflammatory diseases. SFB, which can promote TH17 cell differentiation in
the intestinal mucosa, can exacerbate TH17 dependent peripheral autoimmune
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inflammatory disease such as arthritis, and experimental autoimmune encephalomyelitis
(a murine model for multiple sclerosis) (Kriegel et al., 2011; Wu et al., 2010b). In addition
to regulating intestinal inflammation, signaling through commensal bacteria-derived
SCFA, can limit inflammatory immune responses in murine models of arthritis and
asthma (Maslowski et al., 2009). This body of literature has been crucial in
demonstrating that the commensal bacterial communities can influence the immune
response in multiple tissues.
The mechanism by which signals originating from the intestine have a systemic effect
on the immune response remains unclear. One possible explanation is that bacterial
products translocate across the intestinal epithelium and circulate throughout the host to
stimulate the systemic immune system. In known incidences of bacterial translocation of
commensal bacteria, mice exhibit elevated proinflammatory cytokines in the serum and
spleen and increased expression of immune activation markers (Brenchley et al., 2006;
Sonnenberg et al., 2012). Restifo and colleagues found that bacterial translocation of
intestinal commensal bacteria had an adjuvant effect on the cytotoxic capability of tumorspecific CD8 T cells (Paulos et al., 2007). Combined, these studies suggest that signals
derived from bacteria within the intestine can aid in immune activation throughout the
host. Whether commensal bacteria-derived signals are influencing the systemic immune
system at steady-state, either via basal bacterial translocation or an alternative
mechanism has yet to be examined and will be the focus of Chapter 4 of this thesis.
1.2.6 Commensal bacterial communities influence the immune response to
infection
Commensal bacterial communities can also augment the immune response and aid in
protective immunity against pathogenic infection. For example, SFB, described in
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previous sections to exacerbate immune response in autoimmune inflammatory
diseases, has a protective role following infection with a murine enteropathic bacterium,
Citrobacter rodentium (Ivanov et al., 2009). Clearance of C. rodentium, which induces a
robust TH17 immune response (Mangan et al., 2006), was enhanced in mice colonized
with SFB, a commensal bacteria that drives CD4 TH17 cell differentiation (Ivanov et al.,
2009). In addition, following selective depletion of commensal bacterial communities with
metronidazole, mice are more susceptible to Citrobacter infection, further indicating a
role for commensal bacteria in host immunity (Wlodarska et al., 2011). Belkaid and
colleagues reported that mice depleted of commensal bacterial communities with
antibiotics had diminished IFN-γ and IL-17 production following infection with the
intestinal parasite Encephalitozoon cunniculi. This diminished immune response
correlated with a higher parasite burden compared to wild type mice. In this report, oral
administration of the specific TLR ligand CpG, but not LPS, was sufficient to recapitulate
the immune response in the ABX-treated mice and resulted in parasite clearance in a
TLR9 dependent manner (Hall et al., 2008). ABX-mediated depletion of commensal
bacteria also revealed a critical role for commensal bacteria in protective immunity
following intestinal infection with Toxoplasma gondii, via commensal bacteria driven
stimulation of intestinal DCs (Benson et al., 2009). Studies conducted using another
intestinal pathogen, Salmonella enterica, found that ABX-treatment increased host
susceptibility to Salmonella infection, characterized by increased bacterial translocation
and intestinal inflammation (Croswell et al., 2009; Garner et al., 2009; Sekirov et al.,
2008). Susceptibility to infection-induced colitis persisted in mice for up to two weeks
after termination of ABX treatment suggesting that enduring alterations in the
composition of commensal bacterial communities may be responsible for the inability to
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limit inflammation (Croswell et al., 2009). GF mice, which lack production of the
commensal bacteria induced antimicrobial peptide RegyIII, also exhibit increased
bacterial dissemination when orally challenged with Salmonella typhimurium (Vaishnava
et al., 2008). In contrast to these studies demonstrating that commensal bacteria
augment immunity to infection, commensal bacteria-derived signals can also suppress
immune responses to the benefit of the pathogen. Two studies have demonstrated that
enteric viral infections can use immunoregulatory signals from commensal bacteria to
improve viral infectivity (Kane et al., 2011; Kuss et al., 2011). Combined, these reports
establish an important role for commensal bacterial communities in influencing the
immune response following intestinal bacterial, parasitic, or viral infection.
Few studies, however, have investigated the influence of commensal bacteria-derived
signals on host immune responses to pathogens that infect tissues outside of the
gastrointestinal tract. Early studies reported that GF mice were more susceptible to
influenza A and coxsackie B viral infection (Dolowy and Muldoon, 1964; Schaffer et al.,
1963). However, these studies were limited in the immunological and pathological
parameters examined and failed to address the underlying mechanisms for increased
susceptibility. More recently, Oliveira and colleagues found that GF Swiss/NIH mice
infected with Leishmania major failed to heal skin lesions and had increased parasite
burden at 13 weeks post-infection (Oliveira et al., 2005). Impaired control of Leishmania
in GF mice was attributed to defective macrophage activation and killing of the parasite
(Oliveira et al., 2005). GF mice were also found to have increased susceptibility to
Listeria monocytogenes infection due to impaired T cell homing to sites of infection
(Inagaki et al., 1996). Another study by Tanaka and colleagues reported that GF mice
infected with murine cytomegalovirus had a reduced virus-specific CD8 T cell response
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in the lung compared to conventionally-reared (CNV) mice despite comparable viral
levels (Tanaka et al., 2007). As described in section 1.2.1, GF mice have impaired
development of the immune system. Therefore, the underlying cause of defective
immune responses in GF mice to infection may be an underdeveloped immune system.
To account for this possibility, antibiotics have been employed prior to infection to allow
for normal immune development before disruption of commensal bacteria-derived
signaling. Iwasaki and colleagues reported that antibiotic-mediated manipulation of
commensal bacteria resulted in impaired adaptive immune responses to viral infection in
the lung (Ichinohe et al., 2011). This effect was associated with defective activation of
the inflammasome, a pathway activated by bacterial products that is also important in
conferring protective immunity against a subset of viruses, including influenza virus and
poxviruses (Lamkanfi and Dixit, 2011). This study indicates that commensal bacterial
communities aid in the induction of the immune response to a non-intestinal, mucosalassociated viral infection. Whether depletion of commensal bacteria selectively regulates
inflammasome-dependent

pathways

or

this

observation

represents

broader

immunological crosstalk mechanisms between commensal bacteria and other antiviral
will be addressed in Chapters 2 and 3.

1.3 Immune responses to viral infection
Viruses consist of DNA or RNA encoding genes encapsulated by a protein and/or lipid
coat to protect the genetic material (Alberts et al., 2002). A virus does not possess the
capacity to replicate independently and therefore must gain entry into a cell to access
the molecular machinery necessary to synthesize more copies of itself (Alberts et al.,
2002). The biological goal of a virus upon infection is to replicate without detection by the
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host organism. Viral replication can cause stress and potentially death to the host cell as
resources are diverted to replication of the virus causing accumulation of viral copies
and rupture of the host cell membrane (Alberts et al., 2002). Higher order organisms
have developed an immune system to rapidly detect and clear the virus from the host or,
as is the case in persistent viral infections, control replication and limit virus-induced
tissue damage. The immune system accomplishes this goal through the coordinated
response of multiple specialized cells of the innate and adaptive immune system. This
section will discuss the mechanisms of viral detection and the cells involved in the
antiviral immune response.

1.3.1 Recognition of viral pathogens by the immune system
Detection of a viral infection by the immune system is primarily accomplished by distinct
PRRs that are expressed by immune and non-immune cells and recognize PAMPs
associated with viruses. Viral PRRs initiate a cascade of signaling events that lead to
transcription of a gene program specified for antiviral defense (Seth et al., 2006). A virus
must gain entry into a cell to establish infection and correspondingly most of the PRRs
that detect viruses are located in the cytosol or endosomal compartments. TLRs consist
of a extracellular domain of leucine rich repeats and a cytoplasmic Toll/Interleukin-1
(TIR) signaling domain (Akira and Takeda, 2004). The leucine rich repeat region of the
TLR contains the ligand binding domain of the receptor and provides specificity for
PAMP recognition (Akira and Takeda, 2004). A subset of the TLRs (TLR 3,7,8, and 9)
exhibit binding affinity for various viral derivatives and are expressed in the endosomal
compartment of cells (Akira and Takeda, 2004). TLR3 recognizes double-stranded RNA
and is expressed in most innate immune cells except of plasmacytoid DCs (pDCs) and
neutrophils (Schroder and Bowie, 2005). Deficiency in TLR3 expression can lead to
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decreased production of proinflammatory cytokines and has been shown to correlate
with an impaired ability to suppress herpes simplex virus (Tabeta et al., 2004; Zhang et
al., 2007). TLR7 and TLR8 share the same activating ligand, long single-stranded RNA,
and both drive interferon alpha (IFN-α) production in pDCs (Heil et al., 2004; Lee et al.,
2007). Unmethylated CpG DNA motifs, a common feature found in both bacterial and
viral genomes are the ligands for TLR9, and, therefore, TLR9 has a critical role in
detecting infection by DNA viruses (Hemmi et al., 2000). For example, infection of Tlr9-/mice with a DNA virus such as murine cytomegalovirus results in diminished induction of
type I IFNs and increased mortality compared to wild-type controls (Tabeta et al., 2004).
These endosomal TLRs represent one group of the PRRs that detect viral infection.
Host cells have also evolved to detect viruses replicating in the cytoplasm with a family
of cytosolic PRRs that sense intracellular nucleic acid. The two most well characterized
cytoplasmic nucleic acid sensors of this recently described family are retinoic acidinducible gene (RIG-I) and melanoma differentiation-associated gene 5 (MDA5)
(Thompson et al., 2011). Both of these proteins sense RNA in the cytoplasm, with RIG-I
detecting 5’-triphosphorylated(Hornung et al., 2006; Pichlmair et al., 2006), uncapped
single-strand RNA and MDA5 responding to long double-stranded RNA (Kato et al.,
2006). Ligand binding to these two PRRs leads to recruitment of mitochondrial antiviral
signaling protein (MAVS) followed by activation of NFκB and interferon response factor
(IRF) 3 and 7, which bind to the Ifnβ promoter and initiate transcription (Honda et al.,
2005; Kawai et al., 2005). Mice with genetic deletion of either RIG-I or MDA5 exhibit
increased susceptibility to several viral infections including paramyxoviruses, influenza
virus, Japanese encephalitis virus, and picornavirus, demonstrating the in vivo relevance
of these PRRs in mounting protective antiviral immunity (Kato et al., 2006). In addition to
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RIG-I and MDA5, a growing list of RIG-I-like receptors have been identified and the
importance of these receptors in antiviral defense are just starting to be understood
(Thompson et al., 2011). Collectively, the main function of viral PRRs appears to be to
detect virus inside a host cell and to rapidly initiate a gene program to limit viral
replication and to trigger the immune system into action

1.3.2 Type I IFNs are critical initiators of antiviral immunity
The initial host cell response to viral infection leads to production of several
proinflammatory factors including the type I IFN cytokine family. Type I IFNs, which were
originally identified as a secreted factor that “interfered” with viral replication in culture
(Isaacs and Lindenmann, 1957), are critical in defense against most viruses (Hwang et
al., 1995; Muller et al., 1994). Type I IFNs coordinate the antiviral immune response in
three distinct steps; i.) induction of a gene program to limit viral replication, ii.) activation
innate immune cells, iii) drive CD4 and CD8 T cell differentiation and B cell antibody
production (Figure 3).
The Type I IFNs family consists of IFN-β (a single gene) and IFN-α (gene with multiple
isoforms) and are direct downstream targets of PRRs signaling, such as RIG-I, MDA5
and TLR3, as discussed in the previous section (Thompson et al., 2011). The cellular
source of type I IFNs during a viral infection, in addition to the virus-infected cell itseIf,
are innate immune cells such as pDCs and macrophages, which are stimulated via IFN
signaling in a positive feedback manner to produce more type I IFNs (Jung et al., 2008;
Kumagai et al., 2007). Production of type I IFNs from either of these cell types have
been demonstrated to be critical in supporting the expansion of the antiviral immune
response and control of viral infection (Jung et al., 2008; Kumagai et al., 2007). The type
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I IFN receptor is composed of two subunits (IFNAR1 and IFNAR2) that are expressed
ubiquitously in hematopoietic and non-hematopoietic cells and signal through Janus
kinases prophorylation of the transcription factors STAT1 and STAT2 (Li et al., 1997).
Phosphorylation of STAT1 and STAT2 results in formation of a heterodimer that
associates with IRF9, forming a transcription factor complex (ISGF3), that translocates
to the nucleus and initiates transcription of interferon response genes (IRG) (Trinchieri,
2010). Ablation of type I IFN signaling has lead to well characterized impairments in host
antiviral immunity to multiple viruses, highlighting the ubiquitous need for these cytokines
in defense against viral infection (Moskophidis et al., 1994; Muller et al., 1994).
Expression of IRGs following IFN signaling leads to induction of numerous defense
mechanisms that make the cell refractory to viral replication. For example, IFN signaling
leads to expression of a family of enzymes named 2’-5’ oligoadenylate synthases (OAS)
that activate RNase L, an enzyme that degrades host and viral RNA and therefore limits
viral replication as well as produces dsRNA for RIG-I/MDA5-mediated recognition and
subsequent production of type I IFNs (Malathi et al., 2007; Stark et al., 1998). Other IFNinducible genes such as the Mx and PKR proteins have similar effects of inhibiting the
replication process of the virus (Haller et al., 2007). Further, IFN signaling can cause
infected cells to undergo apoptosis and therefore deny the virus access to the cellular
machinery needed for self-replication (Stetson and Medzhitov, 2006). Programmed cell
death via apoptosis also prevents viral-induced cell lysis and release of newly
synthesized virus. Combined, these type I IFN driven mechanisms of prevention and
containment represent the first line of defense against viruses.
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1.3.3 Induction of the innate immune response to viral infection
In response to viral infection the innate immune system is activated by detection of
cytokines produced by virally infected host cells or cellular debris caused by virusinduced cell death. Innate immune cell types consist of macrophage, DCs, pDCs,
neutrophils, basophils, eosinophils, mast cells, NK cells, and innate lymphoid cells.
These cells exhibit diverse characteristics and functions in response to distinct classes
of pathogens. The broad function of innate immune cells is to be early responders to an
invasive pathogen and coordinate induction of a protective adaptive immune response.
Macrophages and DCs are two innate cell types that are critical antiviral defense and
induction of the adaptive immune system.
Macrophages, crucial sentinel cells of the innate immune system, rapidly respond to
type I IFNs secreted by virally-infected cells by increasing phagocytic activity and
releasing nitric oxides into the local environment which are capable of limiting viral
replication (Fujimoto et al., 2000; Guidotti et al., 2000; Saura et al., 1999). In addition,
macrophages produce an array of proinflammatory chemokines and cytokines that lead
to the recruitment of other effector immune cells and create a proinflammatory cytokine
milieu to shape the immune response (Guidotti and Chisari, 2001; Peschke et al., 1993).
Consistently, studies using macrophage-deficient mice or macrophage depletion
techniques have reported impaired viral clearance and diminished induction of the
adaptive immune response demonstrating the importance of this innate immune cell
following viral infection (Kim et al., 2008; Kumagai et al., 2007; Seiler et al., 1997).
In addition to macrophages, DCs are another innate immune cell population critical in
the propagation of the antiviral immune response. The main purpose of DCs is to
function as antigen presenting cells (APCs) that prime the adaptive immune response.
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DCs specialize in the uptake and processing of antigens into short peptide segments
that are packaged on major histocompatability complex (MHC) class I and II molecules
and presented to T cells (Bevan, 2006; Yewdell and Haeryfar, 2005). DC exposure to
proinflammatory cytokines and/or PRR stimuli creates a feedforward loop, inducing DCs
to produce more proinflammatory chemokines and cytokines, increase antigen uptake,
and upregulate costimulatory molecules such as CD80, CD86 and CD40 (Kato et al.,
2006; Masson et al., 2008; West et al., 2004). DCs migrating from the site of infection to
the draining lymph nodes act in concert with lymphoid resident DCs to present antigen
on MHC class I and II to naïve CD8 and CD 4 T cells (Allenspach et al., 2008; Yewdell
and Haeryfar, 2005). Costimulatory molecule interactions and proinflammatory cytokine
stimulation provide a critical second and third stimulatory signals, along with the initial T
cell receptor-MHC-peptide engagement, to prime naïve T cells and drive T cell
differentiation (Masson et al., 2008). DCs either remain at the site of infection to
stimulate and direct newly recruited innate and adaptive immune cells or migrate to
draining lymph nodes to present viral antigen to naïve CD4 and CD8 T cells leading to
initiation of the adaptive immune response (McGill et al., 2009).

1.3.4 Induction of the adaptive immune response to viral infection
When the initial antiviral mechanisms of the innate immune system are insufficient to
control viral infection the adaptive arm of the immune provides crucial cell-mediated (T
cells) and humoral (antibody producing B cells) immune responses to control viral
infection. The importance of the adaptive immune response has been demonstrated in
several models of viral infection where mice lacking an adaptive immune system can not
control infection and succumb to the viral infection (Franco and Greenberg, 1995;
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Palladino et al., 1995; Xu et al., 2004). Three cell types comprise the adaptive immune
response; Cytotoxic CD8 T cells, CD4 T helper cells and B cells. All of these cell types
express antigen specific surface receptors, the T cell receptor (TCR) or B cell receptor
(BCR), that enable the adaptive immune response to target effector responses against
specific pathogens. Upon stimulation of the TCR or BCR with their cognate antigen CD4,
CD8 T cells and B cells undergo rapid clonal expansion, creating a pool of effector cells
(Hugues et al., 2004). Effector functions include direct cell lysis of virus-infected cells,
production of antiviral effector cytokines, and production of antibodies. Expansion of the
adaptive immune response corresponds with viral clearance and is followed by a
contraction of the effector cells and establishment of a pool of memory cells (Figure 4).
Memory CD4, CD8 T cells and B cells establish long-lasting immunity and prevent
recurrent infections with the same virus (Harrington et al., 2008; Harty and Badovinac,
2008; Slifka et al., 1998).
During a viral infection, in addition to MHC/TCR binding and costimulatory molecule
interaction, CD4 T helper cells receive a third signal from proinflammatory cytokines,
such as type I IFNs and IL-12, that activates a gene program that directs the
differentiation of the CD4 T cell into a TH1 phenotype (Whitmire, 2011). TH1 cells act to
coordinate the adaptive and innate immune response against the virus by producing
cytokines such as IFN-γ and IL-2 that reinforce the antiviral response and aid in T cell
proliferation (Williams and Bevan, 2007). TH1 cells also support B cell antibody
production and isotype class switching through CD40-CD40L interactions (Bishop and
Hostager, 2001). These functions are critical for the antiviral response as loss of the
CD4 T cell responses severely impairs the size and quality of the adaptive immune
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response and can lead to persisting viral infection and host mortality (Leist et al., 1989;
Louten et al., 2006; Xu et al., 2004).
Cytotoxic CD8 T cells limit viral infection by directly targeting and eliminating virallyinfected cells or producing antiviral cytokines. CD8 T cell-mediated cell lysis can occur
via ligand mediated cell death (Fas/FasL interaction) (Topham et al., 1997) (Trapani and
Smyth, 2002) or production and release of cytotoxic lytic granules, such as perforin and
granzyme, at the interface of the CD8 T cell and target cell (Hou and Doherty, 1995;
Peters et al., 1991). CD8 T cells also produce of effector cytokines IFN-γ and TNF-α that
can directly induce cell programmed death or stimulate surrounding innate cells, such as
macrophages and NK cells, to increase cytolytic activity (Kaech et al., 2002). Studies in
mice deficient of CD8 T cells have reported impaired viral clearance and decreased host
survival demonstrating the essential role of the CD8 T cell response has in protective
antiviral immunity (Fung-Leung et al., 1991; Qi et al., 2006).
Through the BCR, B cells can detect virus as soluble antigens in the lymphatics or in
the virus’ native form on the surface of macrophages or DCs (Depoil et al., 2008; Junt et
al., 2007; Qi et al., 2006). Endocytosis of antigen through BCR binding, leads to antigen
processing and presentation on MHC-II molecules allowing B cells function as an
addition APC driving T cell proliferation (Crawford et al., 2006). In addition, B cells
secrete virus-specific antibodies that can either neutralize free virus or bind to a virallyinfected cell and target it for antibody dependent cell-mediated cytotoxicity. The
importance of the B cell response during primary viral infection varies for different
viruses, but in general, the primary B cell response aids in the latter stages of viral
clearance (Franco and Greenberg, 1995; Graham and Braciale, 1997; Palladino et al.,
1995). Following primary infection, germinal center reactions and B cell affinity
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maturation leads to the differentiation of long lived plasma cells that secrete high affinity
antibodies into circulation and are highly effective at preventing secondary infection
(Franco and Greenberg, 1995; Tarlinton, 2006). Combined the cells of the adaptive
immune system direct a targeted response to control viral infection in the host.

1.4 Two models of viral infections: mucosal-associated influenza virus and
systemic Lymphocytic Choriomeningitis virus
1.4.1 Influenza virus and pathogenicity
Seasonal influenza virus infection results in a significant burden on the health system
causing approximately 200,000 hospitalizations and 36,000 deaths in the United States
annually (Thompson et al., 2003). The most susceptible populations are infants, the
elderly, or individuals with pre-existing health concerns (Thompson et al., 2003).
However, influenza pandemics, caused by introduction of a new subtype of influenza
virus into the population can cause death in otherwise healthy adults, as was the case in
1918 with the Spanish flu epidemic or the more recent H5N1 highly pathogenic avian
influenza virus, (Taubenberger and Morens, 2008; Webster and Govorkova, 2006).
Inflammation and tissue damage resulting from influenza virus infection is predominantly
localized to the lung and is characterized by pulmonary hemorrhaging and edema,
inflammatory infiltrates, and necrotizing bronchitis (Taubenberger and Morens, 2008).
Mouse-adapted influenza viral strains mimic disease pathogenesis in humans and
provide an excellent model to study the immune response to the virus and formation of
protective immunity (Kuiken et al., 2010). The murine viral infection model will be used in
Chapter 2 to study virus-induced pathology and immune responses to a local, non27

intestinal, mucosal-associated viral infection following disruption of commensal bacterial
communities.
Influenza A virus is an enveloped, single-stranded RNA virus member of the
Orthomyxoviridae family (Cheung and Poon, 2007). The virus is composed of eight RNA
gene segments that encode ten proteins, two of these proteins, hemagglutinin (HA) and
neuraminidase (NA), are expressed on the viral capsid and are highly immunogenic
epitopes that serve as direct targets for neutralizing antibodies (Cheung and Poon,
2007). Influenza virus primarily infects respiratory epithelial cells but can also infect
alveolar macrophages and other immune cells that are recruited to the site of infection
causing cell death by cytolysis or apoptosis within forty hours of infection (Julkunen et
al., 2001). Severity of the influenza virus infection depends on a combination of hostderived and viral-specific factors. Multiple influenza virus strains have been adopted for
the murine model and cause different degrees of pathology. In this thesis the H1N1
influenza A/Puerto Rico/8/34 strain (PR8) and the A/X-31 H3N2 strain (X31) will be
employed. In immunocompetent mice, infection with a low dose of PR8 virus (~300
TCID50) causes significant morbidity and lung tissue damage lasting 1-2 weeks. X31 viral
infection, even when administered at a much higher dose (~1x105 TCID50), is cleared
from the mouse at a quicker rate and causes substantially less morbidity (Bouvier and
Lowen, 2010; Decman et al., 2010)(personal observations). Morbidity can be monitored
by weight loss and/or blood oxygen saturation levels, enabling non-invasive measures of
disease progression (Verhoeven et al., 2009). These two influenza virus strains will be
used in Chapter 2 to assess the protective capacity of the antiviral immune response.
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1.4.2 The immune response to influenza virus infection
Successful clearance of influenza virus infection requires a coordinated innate and
adaptive immune response. Defects in PRR expression (Ichinohe et al., 2011; Kato et
al., 2006), the IFN signaling pathway (Mordstein et al., 2010; Price et al., 2000), DC
(McGill et al., 2008), macrophage (El Bakkouri et al., 2011; Kumagai et al., 2007), CD8 T
cells (Epstein et al., 1993) and B cells (Graham and Braciale, 1997) all lead to increased
host mortality following challenge with influenza virus demonstrating the importance of
each arm of the immune system in controlling influenza virus infection. Infected
respiratory epithelial cells initiate the immune response by producing type I IFNs and
chemokines to recruit and activate innate immune cells into the lung (Julkunen et al.,
2001; Sanders et al., 2011). Resident alveolar macrophages and DCs are activated by
IFN stimulation and produce proinflammatory factors to increase the magnitude of the
response (McGill et al., 2009). Neutrophils, NK cells and inflammatory monocytes are
recruited to the lung and in combination with alveolar macrophages clear virally-infected
cells and cellular debris (Hermesh et al., 2010; Tate et al., 2009; Tumpey et al., 2005).
Meanwhile, DCs migrate to the draining mediastinal lymph nodes to present antigen to
naïve CD4 and CD8 T cells to initiate the adaptive immune response (Belz et al., 2004;
Kim and Braciale, 2009). Following clonal expansion, virus-specific T cells home to the
lung starting around 6-7 days post-infection and produce effector cytokines and induce
apoptosis via secretion of lytic granules and Fas/FasL interactions (Topham et al.,
1997). Induction and recruitment of the adaptive immune response rapidly leads to viral
clearance by approximately day 10-12 post-infection (Kohlmeier and Woodland, 2009).
However, if the immune response is delayed or defective, influenza virus infection can
cause severe damage to the lung tissue, disrupting gas exchange that can potentially be
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fatal. This fine balance highlights the critical nature for a rapid and robust immune
response to viral infection.

1.4.3 Lymphocytic Choriomeningitis virus and pathogenicity
Lymphocytic Choriomeningitis Virus (LCMV) is an enveloped, single-stranded RNA virus
belonging to the Arenaviridae family (Oldstone, 2002a). Unlike influenza virus, LCMV is
a natural murine pathogen that results in a systemic infection with virus circulating
through the blood to infect multiple tissues of the host (Ahmed et al., 1987; Sydora et al.,
1996). As a non-cytolytic virus, most of the inflammation and tissue damage associated
with LCMV infection is induced by the cytotoxic effects of the inflammatory immune
response (Khanolkar et al., 2002). LCMV gains access to a cell through binding with the
α-dystroglycan receptor, a cell surface receptor for proteins of the extracellular matrix
that is ubiquitously expressed in multiple tissues (Cao et al., 1998; Rojek et al., 2007).
The cell tropism and replicative capacity of LCMV varies from between strains. For
example, the Armstrong (Arm) strain of LCMV establishes an acute infection that is
rapidly controlled and cleared by the host within a week (Ahmed et al., 1984a; Ahmed et
al., 1984b). On the other end of the spectrum the clone 13 strain (cl-13), which carries
two point mutations increasing α-dystroglycan receptor affinity and viral polymerase
activity (Cao et al., 1998; Matloubian et al., 1993), exhibits increased macrophagetropism and results in prolonged viremia and persisting virus in immunoprivileged organs
such as the kidney and central nervous system (Ahmed et al., 1984b; King et al., 1990).
The LCMV strain used in this thesis, T1b, exhibits a lymphocyte-tropism and results
viremia lasting approximately 2 weeks (Blackburn et al., 2009; King et al., 1990). The
intermediate phenotype of this LCMV strain can be exploited to identify defects in
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antiviral immunity that might otherwise be unobserved with an acute or chronic LCMV
strain. Characterization of the immune response to LCMV infection has led to the
development of molecular tools, such as identification of virus-specific T cells by MHCtetramer staining, which enable a comprehensive analysis of the antiviral immune
response (Altman et al., 1996) (Oldstone, 2002b). These studies have greatly improved
our understanding of the innate and adaptive antiviral immune response and the tools
developed in the LCMV infection system will be employed in Chapter 3 to address the
influence of commensal bacterial communities on the immune response to a systemic
viral infection.

1.4.4 The immune response to Lymphocytic Choriomeningitis virus
The immune response to LCMV has been extensively characterized and has served as
a prototypic model to study the immune response to viral infection. Because LCMV
infects multiple organs of the host, there is not one anatomical location that recruits
activated immune cells as is the case in influenza virus infection of the lung. Instead
activated effector cells of the innate and adaptive immune system can be found in
multiple organs.
Similar to other viral infections, LCMV is capable of stimulating PRRs RIG-I, MDA5,
TLR3, 7, and 9 to induce an early burst of type I IFN production that initiate the immune
response (Lee et al., 2009; Zhou et al., 2010). However, signaling via TLR7 and 9,
particularly in plasmacytoid DCs, is the predominant source of type I IFN production
immediately following LCMV infection. (Jung et al., 2008; Montoya et al., 2005).
Disruption of TLR signaling via genetic knockout of the TLR signaling protein MyD88,
results in significantly decreased type I IFN levels in the serum and diminished innate
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and adaptive immune response leading to persisting viral titers in the host (Chen et al.,
2005; Jung et al., 2008; Kolumam et al., 2005; Zhou et al., 2005). DCs and macrophage
have separate but critical roles in initiating a protective immune response. As early as 48
hours post-infection, splenic DCs upregulate costimulatory markers CD80, CD86, and
CD40 and are producing proinflammatory cytokines to direct T cell expansion and
differentiation (Belz et al., 2005; Montoya et al., 2005). Deletion of DCs results in a
diminished LCMV-specific CD8 T cell population demonstrating that DCs are the
predominant APC in LCMV infection (Probst and van den Broek, 2005). Macrophages,
stimulated by IFN signaling, increase phagocytic activity and are important in limiting
spread of viral infection (Lang et al., 2010). Macrophage activation at this early stage of
infection before the adaptive immune response has been primed is a critical determinant
in whether the virus is ultimately cleared (Lang et al., 2010; Oehen et al., 2002; Seiler et
al., 1997).
LCMV infection induces both a cell-mediated and humoral arms of the adaptive
immune system, but the T cell response, particularly the CD8 T cell response has been
the more extensively studied and characterized (Hangartner et al., 2006; Khanolkar et
al., 2002; McDermott and Varga, 2011). The virus-specific CD8 T cell response robustly
expands and migrates to infected tissue, aiding in viral clearance through cell-mediated
cytotoxicity and production of effector cytokines such as IFN-γ and TNF-α (Ahmed et al.,
1984a; Khanolkar et al., 2002). Control of acute LCMV infection is dependent on the
CD8 T cell response as loss of these cells or ablation of their effector mechanisms
results in persisting viral infection (Fung-Leung et al., 1991; Intlekofer et al., 2008; Kagi
et al., 1995). Infection with chronic strains of LCMV lead to defective CD8 T cell
responses, termed CD8 T cell exhaustion, that is characterized by upregulation of
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inhibitory receptors and progressive loss of effector function (Blackburn et al., 2009;
Wherry, 2011; Wherry et al., 2003; Zajac et al., 1998). Because of the tight link between
the LCMV-specific CD8 T cell response and viral progression, characterizing the quality
of the CD8 T cell response is an excellent indicator of the overall ability of the host to
respond to and control viral infection (Fuller et al., 2004; Wherry et al., 2005). As such, it
will be used in Chapter 3 of thesis to assess the quality of the antiviral immune response
to a systemic viral infection following depletion of commensal bacterial communities.

1.5 Outline of Thesis
It is increasingly apparent that the commensal bacterial communities can shape immune
cell development and function. Commensal bacterial communities have been
demonstrated to have either an adjuvant or immunoregulatory effect in the context of
intestinal infection. The focus of this thesis will be to explore the influence of commensal
bacterial communities on antiviral immunity to non-intestinal viral infections. Through use
antibiotic-mediated disruption of commensal bacterial communities or GF mice, Chapter
2 will address whether commensal bacterial communities aid in induction of a host
protective immune response following infection with influenza virus. The impact of
commensal bacteria-derived signals on immunity to a systemic viral infection will be
investigated in Chapter 3 through probing the innate and adaptive immune response to
LCMV following depletion of commensal bacterial communities. Lastly, Chapter 4 will
examine the fundamental role for commensal bacteria-derived signals in calibrating the
activation threshold of the innate immune system required for immunity to viral infection.
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Figure 1. Composition of intestinal bacterial communities.

Figure 1. (A) Quantification of bacterial phyla based on total bacterial 16S rDNA in stool
samples isolated from naïve, conventionally‐reared, C57BL/6 mice. (B) Phylum level
classification of intestinal bacterial communities of naïve C57BL/6 mice based on 16S rDNA
frequencies in stool sample. (Adapted from (Hill et al., 2010)).
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Figure 2. Commensal bacteria-derived signals regulate intestinal immune
homeostasis.

Figure 2. Specific signals, derived from intestinal bacterial communities, stimulate different
cell types within the intestine (e.g. DCs and IECs). Commensal bacteria‐derived signals can
influence DCs and IECs to induce either an immunoregulatory or proinflammatory cytokine
environment. This cytokine mileu of the intestinal microenvironment can condition antigen
presenting cells and influence CD4+ T cell differentiation within the intestinal mucosa.
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Figure 3. Type I Interferons initiate multiple phases of host antiviral defense.

Figure 3. Following viral infection of a cell, PRR signaling initiates Type I IFN production (IFN‐
α/β), which shapes the host antiviral response in three phases. (1) Type I IFNs act in an
autocrine or paracrine manner to induce transcription of interferon response genes (IRGs)
that limit viral replication. (2) Sentinel innate immune cells, such as macrophages and DCs,
are stimulated by Type I IFN to produce proinflammatory cytokines, increase antigen
processing and presentation, and upregulate costimulatory molecules. (3) Type I IFN
stimulation contributes to CD4 and CD8 T cell expansion and B cell antibody prodution.
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Figure 4. Kinetics of the adaptive immune response to viral infection.

Figure 4. The cell‐mediated (CD4 and CD8 T cells) and humoral (B cells) arms of the adaptive
immune response expand in response to viral infection. Following control of viral infection,
memory populations of all three adaptive immune cell types are established and prevent
recurrent infection.
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Chapter 2
Loss of commensal bacterial communities results in impaired
immunity to influenza virus infection in the lung
2.1 Abstract
Commensal bacterial communities regulate intestinal immune cell development and
differentiation. Furthermore, commensal bacteria-derived signals can act as an adjuvant
in augmenting the immune response against intestinal infections. However, whether
alterations in commensal bacterial communities can influence host protective immunity
to viral infection in tissues outside of the intestinal tract remains poorly defined. In this
chapter, I identify a role for commensal bacteria-derived signals in promoting protective
antiviral immunity following influenza virus infection. Antibiotic (ABX)-treated mice
challenged with two different strains of influenza A virus (PR8 or X31) exhibited impaired
lung function and severe bronchiole epithelial degeneration following infection, resulting
in increased host mortality. ABX-treated mice exhibited a diminished adaptive immune
response that correlated with elevated viral titers in the lung. Further, ABX-treated mice
exhibited a defective innate immune response characterized by decreased production of
proinflammatory cytokines and chemokines in the lung and reduced expression of IFNinduced antiviral defense genes in alveolar macrophages at day 3 post-infection.
Restoration of IFN responsiveness in ABX-treated mice re-established protective
antiviral immunity after influenza virus infection. Taken together, these data indicate that
signals derived from commensal bacterial communities regulate the innate and adaptive
immune response that is critical for host survival following respiratory viral infection.
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2.2 Introduction
Commensal microbial communities that colonize the barrier surfaces of the skin, vaginal,
upper respiratory, and gastrointestinal tract of mammals consist of parasites, bacteria,
fungi and viruses (Breitbart et al., 2003; Ley et al., 2006a; Scupham et al., 2006). The
largest and most diverse microbial communities reside within the intestine where nonculture based methods have identified an estimated 15,000-36,000 individual bacterial
species (Eckburg et al., 2005; Frank et al., 2007; Wang et al., 2003). These commensal
bacteria have multiple beneficial properties ranging from aiding in metabolism to
competing with invasive pathogens to occupy an environmental niche (Hooper and
Gordon, 2001; Macpherson and Harris, 2004; Sonnenburg et al., 2006). Recent studies
in patients have identified that alterations in the composition of bacterial communities are
associated with susceptibility to diabetes, obesity, cancer, inflammatory bowl disease
(IBD), allergy and other atopic disorders, highlighting the potential impact of hostcommensal interactions in influencing multiple metabolic and chronic inflammatory
diseases (Ley et al., 2006b; Manichanh et al., 2006; Moore and Moore, 1995; Penders et
al., 2007a; Penders et al., 2007b).
Studies utilizing gnotobiotic (germ-free), antibiotic-treated or selectively colonized mice
have demonstrated that the absence or alterations in composition of commensal
bacterial communities results in impaired lymphoid tissue development, dysregulated
immune cell homeostasis and altered susceptibility to multiple infectious or inflammatory
diseases in the gastrointestinal tract (Amaral et al., 2008; Herbst et al.; Smith et al.,
2007; Souza et al., 2004). For example, Mazmanian and colleagues identified a
zwitterionic polysaccharide (PSA) isolated from Bacteroides fragilis that ameliorated
intestinal inflammation in two murine models of IBD (Mazmanian et al., 2008). In contrast
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colonization of the intestine with Segmented Filamentous Bacteria (SFB), is associated
with increased frequencies of CD4+ TH17 cells in the lamina propria of mice, a
proinflammatory subset of CD4 T cells. (Ivanov et al., 2009; Ivanov et al., 2008).
Consistent with a proinflammatory role, signals derived from commensal bacteria can act
as an adjuvant, augmenting immune responses following parasitic or bacterial infections
of the intestine (Benson et al., 2009; Hall et al., 2008; Ivanov et al., 2009).

Thus,

depending on the context, commensal bacteria-derived signals are capable of
dampening or exacerbating inflammatory immune responses in the intestinal
microenvironment. However, the role of commensal bacteria-derived signals in
augmenting the immune response to infection in tissues distal to the gastrointestinal
tract remains largely unexplored.
The immune response to respiratory viral infections must efficiently clear virus from the
lung tissue while limiting tissue damage to this important barrier surface. Proper
regulation of this delicate balance is vital to host survival and requires rapid induction of
the antiviral immune response followed by prompt cessation of effector mechanisms
upon control of the pathogen. It is unknown whether signals derived from commensal
bacterial communities contribute to modulating the immune response to respiratory viral
infection in a manner similar to what has been observed during intestinal infections. To
address this question, the commensal bacterial communities of mice were deliberately
manipulated by antibiotic treatment and challenged with influenza virus.
Influenza virus is a cytolytic virus that infects the epithelial cells of the respiratory tract
leading to severe lung pathology (Julkunen et al., 2001). Host protection is dependent on
a coordinated innate and adaptive immune response to control viral replication
(Kohlmeier and Woodland, 2009; McGill et al., 2009). Following alteration or absence of
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commensal bacterial communities, however, influenza virus-infected mice were unable
to clear the virus, exhibited severe degeneration of the bronchiole epithelial layer and
succumbed to infection. These antibiotic-treated (ABX) mice exhibited an impaired
innate and adaptive immune response indicating that commensal bacteria-derived
signals are important in augmenting the immune response to viral infection of the
respiratory tract.

2.3 Methods
2.3.1 Mice and viruses
C57BL/6 mice (4-6 weeks old) were purchased from the National Cancer Institute
(Frederick, MD). Mice were maintained in specific pathogen–free facilities at the
University of Pennsylvania. GF C57BL/6 mice were maintained in plastic isolator units
and fed autoclaved chow and water. The University of Pennsylvania Institutional Animal
Care and Use Committee (IACUC) approved all protocols, and all experiments were
performed according to the guidelines of the University of Pennsylvania IACUC.
Mice were inoculated intranasally (i.n.) with recombinant influenza viruses expressing
the LCMV GP33 (PR8-GP33: 368 TCID50, X31-GP33: 1x105 TCID50). Recombinant
influenza virus strains containing the LCMV GP33–41 epitope inserted in the
neuraminidase stalk region were obtained from Dr. Richard J. Webby (St. Jude
Children’s Research Hospital, Memphis, TN), propagated in eggs, and stored at -80°C.
The replication and pathogenicity of these recombinant strains of X31 and PR8 were not
substantially different from their non-recombinant counterparts (data not shown). Prior to
i.n. infections, mice were anesthetized by intraperitoneal (i.p.) injection of 0.2 mL of
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Avertin (2-2-2 Tribromoethanol dissolved in tert-amyl alcohol (Sigma-Aldrich); working
stock 20 mg/mL diluted in PBS).
2.3.2 Oral antibiotic treatment
Mice were provided autoclaved drinking water supplemented with ampicillin (0.5 mg/mL,
Sigma), gentamicin (0.5 mg/mL, Gemini Bio-Products), metronidazole (0.5 mg/mL
Sigma), neomycin (0.5 mg/mL, Med-Pharmex), vancomycin (0.25 mg/mL, Novaplus),
and sucralose (4mg/mL, Splenda, McNeil Nutritionals, LLC). Splenda was added to
make the antibiotic cocktail more palatable. Antibiotic treatment was started 2-4 weeks
prior to infection and continued for the duration of the experiment.
2.3.3 16s rDNA isolation and tracheal bacterial cultures
Stool pellets were collected 2 weeks following antibiotic treatment and total DNA was
extracted using QIAamp DNA stool Mini Kit (Qiagen). Quantification of 16S rDNA was
performed by qRT-PCR using degenerate bacterial 16S rDNA-specific primers (5’AGAGTTTGATCCTGGCTCAG-3’; forward), (5’-CTGCTGCCTYCCGTA-3’; reverse), (5’FAM-TA+ACA+CATG+CA+AGTC+GA-BHQ1-3’; probe; + precedes the position of LNA
base).
Trachea tissue segment was isolated under sterile conditions with particular attention
to ensuring the trachea sample was separated from the esophagus. An approximate 2-3
cm portion of the trachea from the bottom of the larynx to where the trachea splits into
the bronchioli was removed and mechanically homogenized in PBS. The resultant
homogenate was plated by serial dilution on LB agar plates and grown under aerobic or
anaerobic conditions for 48 hours.
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2.3.4 Pulse oximetry
Mice were anesthetized with Avertin then neck and throat hair was removed with a
chemical depilatory agent (Nair, Church & Dwight Co.) one day prior to infection.
MouseOx Tm Pulse-Oximeter neck sensors (Starr Life Sciences, Oakmount, PA) were
placed on exposed skin and blood oxygen saturation was recorded with Starr MouseOx
software v. 5.1. Pulse oximetry readings were allowed to stabilize and fifteen seconds of
measurements were averaged.
2.3.5 Isolation of cells from the lung parenchyma and bronchiole alveolar lavage
fluid
Bronchoalveolar lavage cells (BAL) were obtained by inflating the lung with PBS via the
tracheal cannula and recovering the PBS wash. This was repeated 2x to obtain
increased cellular yield. The lung was perfused by cutting the hepatic vein and injecting
PBS into the right ventricle. The excised lung was cut into small pieces and digested
with 1 mg/mL collagenase D (Roche) and 20 µg/mL DNase Type IV (Sigma-Aldrich) in
complete media (DMEM supplemented w/ 10% FBS, 10µg/mL penicillin/streptomycin,
10mM HEPES, 0.5mM β-mercaptoethanol, 10µg/mL L-glutamine, 5mM sodium
pyruvate) for 30 min at 37°C under constant agitation. Single cell suspensions were
obtained by mechanical disruption through 70µm cell strainers followed by red blood cell
(RBC) lysis.

2.3.6 Flow cytometry, cell sorting, tetramer, and intracellular cytokine staining
Single cell suspensions were surface stained in FACS Buffer (PBS, 2% BSA, 0.2mg
Sodium Azide, 2mM EDTA) using standard flow cytometric staining protocol with
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fluorescently conjugated antibodies specific to CD3ε, CD4, CD8α, CD11c, CD19, CD25,
CD43,

CD45,

CD69,

CD160,

F4/80,

Ly6c,

MHC-I

(H-2Kb),

MHC-II

(I-A/I-E)

(eBioscience), CD5, CD44, CD80, CD86, Ly6g (clone 1A8), ICOS, LAG-3, PD-1 (clone
RMP1-30) (Biolegend), CD40 (BD Biosciences), CXCR3 (R&D Systems), 2B4 (BD
Pharmingen), CD11b, and granzyme B (Invitrogen). Major histocompatibility complex
(MHC) class I peptide tetramers were made and used to identify virus-specific CD8 T
cells (Altman et al., 1996). Alveolar macrophages were identified as Non-T, Non-B, NonNK cells (NTNBNNK), CD11c+, F4/80+. Inflammatory monocytes were identified as
NTNBNNK, CD11c-, F4/80-, Ly6g-, Ly6c+, CD11b+. Neutrophils were identified as
NTNBNNK, CD11c-, F4/80-, Ly6g+, CD11b+. Dendritic cells were identified as
NTNBNNK, F4/80-, CD11c+, MHC-IIhi. Plasmacytoid dendritic cells were identified as
NTNBNNK, non-alveolar macrophage, non-inflammatory monocyte, non-neutrophil,
CD11cint, PDCA-1+. Alveolar macrophages from naïve or d3 PR8-gp33 virus infected
CNV or ABX-treated mice were sorted directly into TRIzol LS (Invitrogen) using a BD
Aria (Beckson Dickson). Additional macrophages from the sample were separately
sorted to ensure sort purity (≥95%). For intracellular cytokine analysis, 106 splenocytes
or 105 cells isolated from the lung were cultured in a 96-well plate in complete media with
viral peptides (0.2 µg/ml) and brefeldin A (Golgiplug, eBioscience) for 5 hrs at 37°C.
After staining for surface antigens as described above, cells were stained for intracellular
cytokines using the Cytofix/Cytoperm kit (BD/Pharmingen) and fluorescently conjugated
antibodies specific for IL-2 (eBioscience), IFN-γ (BD Pharmingen), TNF-α (Biolegend),
MIP-1α (R&D Systems). The CD107a assay was performed as previously described
(Blackburn et al., 2009). Cell viability was assessed with Live/Dead AQUA stain
(Invitrogen). Samples were collected by using a LSR II flow cytometer (Becton
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Dickinson). All flow cytometry data was analyzed by FlowJo v 8.8 (Treestar). Pie charts
were created using the Pestle and SPICE programs (Mario Roederer; Vaccine Research
Center, NIAID, NIH).
2.3.7 Virus-specific antibody and cytokine ELISA
PR8 IgM and IgG serum antibody concentrations were determined by ELISA as
previously described (Ahmed et al., 1984b; Mozdzanowska et al., 2000). In brief, 1,000
HAU/mL of purified PR8 was adsorbed to plates and bound antibody was detected using
anti-IgM or -IgG conjugated to alkaline phosphatase (Sigma) and developed with pnitrophenol phosphate (Sigma). PR8 antibody concentrations were determined using
anti-HA antibody standards of IgM (clone H35-C7-2R1) or IgG (clone H36-4-5.2). Optical
densities (OD405-750) were measured using an ELISA reader and concentrations
calculated using SoftMax Pro software (Molecular Devices). BAL wash supernatant were
analyzed for cytokines and chemokines by luminex multiplex bead array (Millipore).
2.3.8 RNA isolation, cDNA preparation, and RT-PCR
RNA was isolated from cells using an RNeasy mini-kit (Qiagen) and from lung tissue
using mechanical homogenization and TRIzol isolation (Invitrogen) according to the
manufacturer’s

instructions.

cDNA

was

generated

using

SuperScript

reverse

transcriptase (Invitrogen). RT-PCR was performed on cDNA using SYBR green
chemistry (Applied Biosystems) and commercially available primer sets (Qiagen). PA
influenza-specific primers and probes (Sense: CGGTCCAAATTCCTGCTGAT; AntiSense:

CATTGGGTTCCTTCCATCCA;

Probe:

CCAAGTCATGAAGGAGAGGGAATACCGCT) were used in combination with Taqman
PCR Master Mix (ABI) to determine influenza virus genome copies then converted to
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TCID50/ gram of lung tissue. Reactions were run on an RT-PCR system (ABI7500;
Applied Biosystems). Genes of interest were normalized to β-actin and displayed as fold
difference relative to uninfected CNV control mice.
2.3.9 Histological sections and pathology
Lungs were inflated with 4% paraformaldehyde, embedded in paraffin and 5-µm sections
were cut and stained with hematoxylin and eosin. Blind scoring of H&E-stained lung
tissue sections by a board-certified veterinary pathologist reflect degree of luminal
exudates (0-5) and degree of bronchiole epithelial degeneration and necrosis (0-5), for
an overall maximum score of 10.
2.3.10 Poly I:C administration in influenza virus infected mice
ABX-treated mice were administered 30µg of polyinosinic-polycytidylic acid (poly I:C Sigma) i.n. at d -1 and 100µg i.p. at d3 post influenza virus infection (PR8-GP33).
Control CNV and ABX-treated mice received 30µl of PBS i.n. at d -1 and 100µl i.p. at d3.
2.3.11 Statistical analysis
Results represent means ± SEM. Statistical significance was determined by the
unpaired, two tailed, Student’s t-test for individual timepoints, two-way ANOVA test for
timecourse experiments, logrank test for survival curve, or two-part t-test for comparison
of groups that contained samples that were below the limit of assay detection. Statistical
analyses were performed using Prism GraphPad software v4.0. (*p < 0.05; **p < 0.01;
***p < 0.001).
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2.4 Results
2.4.1 Antibiotic-mediated alterations of commensal bacterial communities result
in enhanced susceptibility to influenza A virus infection.
Signals derived from commensal bacterial communities regulate intestinal immune cell
homeostasis and susceptibility to multiple inflammatory diseases in the gastrointestinal
tract (Garrett et al., 2010b; Honda and Littman, 2012; Rakoff-Nahoum et al., 2004;
Round and Mazmanian, 2009). Furthermore, depletion of commensal bacteria leads to
impaired anti-pathogen immune responses to intestinal parasitic and bacterial infections,
indicating an adjuvant-like role for commensal bacteria-derived signals in augmenting
the immune response to intestinal infection (Benson et al., 2009; Hall et al., 2008; Ivanov
et al., 2009). However, it is not clear whether commensal bacteria-derived signals
regulate immunity to viral pathogens that infect sites distal to the gastrointestinal tract.
To address this question, naïve C57BL/6 mice were orally administrated broad-spectrum
antibiotics for two weeks, subsequently infected with influenza virus (H1N1 influenza
A/Puerto Rico/8/34 strain with LCMV GP33 epitope) and immunologic, virologic and
pathologic parameters were analyzed.
As reported previously, antibiotic treatment resulted in a significant reduction of
commensal bacteria along the intestinal tract as well as a dramatic shift in the
composition of intestinal bacterial communities (Figure 5A) (Hill et al., 2010; Hill et al.,
2012). In addition, trachea homogenate samples from conventionally-reared (CNV) or
antibiotic (ABX) treated mice were cultured under aerobic and anaerobic conditions to
examined the impact of antibiotic treatment on the composition of commensal bacterial
communities of the upper respiratory tract. Similar to the gastrointestinal tract, there was
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a loss of culturable aerobic and anaerobic commensal bacteria in the upper respiratory
tract of ABX-treated mice compared to CNV mice (Figure 5B). Despite the loss of
culturable commensal bacteria in the upper respiratory tract, the lung architecture
(Figure 5C) and composition of lung resident immune cells (Figure 5D) remained
unchanged in the steady-state in ABX-treated mice compared to CNV mice.
Following exposure to influenza virus infection, CNV mice lost approximately 20% of
their original body weight (Figure 6A) and had reduced lung function as measured by
blood oxygen saturation at day 10 (d10) post-infection (Figure 6B). Approximately 80%
of the mice were able to recover and clear virus from the lungs by d12 post-infection
(Figure 6C,D). In contrast, ABX-treated mice lost significantly more weight and had a
drastic drop in blood oxygen saturation following influenza virus infection (Figure 6A,B).
Further, ABX-treated mice had significantly higher viral titers in the lung (Figure 6C) and
increased mortality (Figure 6D), demonstrating a deleterious physiological consequence
of altering commensal bacterial communities in the context of respiratory influenza virus
infection.

2.4.2 ABX-treated mice exhibit severe lung pathology following influenza virus
infection
Histopathological examination of lung sections from CNV mice at d12 post-infection
compared to uninfected control mice (Figure 5C) revealed peribronchiolar inflammation
and epithelial hyperplasia, suggestive of wound healing and tissue repair (Figure 7A,B).
Consistent with impaired lung function and increased mortality, lung sections from ABXtreated mice at d12 post-infection revealed more pronounced epithelial cell necrosis
(Figure 7C,D), increased exudate and dead cells in the bronchiolar lumen (Figure 7E,
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arrows), and in the most severe cases, complete loss of the bronchiole epithelial layer
(Figure 7F, arrows). Scoring of histological sections of the lung confirmed increased
prevalence of epithelial cells with morphologic features of degeneration and necrosis in
ABX-treated mice relative to CNV mice (Figure 7G). In agreement with histologic
analysis, increased cell death was observed in the bronchiole alveolar lavage (BAL) fluid
of ABX-treated mice at d12 post-infection compared to CNV mice following staining with
a cellular viability dye (Figure 7H,I).
To further explore the relationship between commensal bacterial communities and
antiviral immunity, gnotobiotic or “germ-free” (GF) mice were infected with influenza virus
and compared to CNV and ABX-treated mice. Similar to a previously published report
(Dolowy and Muldoon, 1964), GF, as well as ABX-treated mice, exhibited increased
weight loss (Figure 8A), impaired viral clearance (Figure 8B) and reduced virus-specific
antibody titers (Figure 8C) compared to CNV mice. Histological examination of the lung
at d12 post-infection revealed more severe bronchiole epithelial degeneration in GF and
ABX-treated mice compared to CNV mice (Figure 8D-F). These data support a critical
role for commensal bacteria-derived signals in promoting optimal antiviral immunity.
2.4.3 ABX-treated mice exhibit a diminished influenza virus-specific adaptive
immune response
Increased lung pathology and impaired viral clearance in ABX-treated mice suggests an
impaired immune response to influenza virus infection. The cell-mediated and humoral
adaptive immune response is critical for viral clearance and host survival (Palladino et
al., 1995; Wu et al., 2010a). To interrogate the adaptive immune response CNV and
ABX-treated influenza virus-infected mice were sacrificed at d7 post-infection.
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Histological examination of the lung revealed significant recruitment of lymphocytes into
the alveolar spaces of CNV mice while ABX-treated mice had relatively diminished
lymphocyte infiltration (Figure 9A). Quantification by flow cytometric analysis confirmed
significantly fewer CD8 T cells in the lung parenchyma and bronchiole alveolar lavage
fluid (BAL) of ABX-treated mice compared to CNV mice (Figure 9B,C).
Major histocompatability complex (MHC) class I tetramer specific for the gp33-41
epitope (Altman et al., 1996), expressed by recombinant PR8-GP33 virus, or tetramer
specific for the endogenous np366-374 amino acid sequence of nucleoprotein of
influenza virus (the two dominant CD8 T cell epitopes for influenza virus) were employed
to more thoroughly investigate the influenza virus-specific CD8 T cell response. CNV
mice infected with PR8-GP33 virus generated large populations of influenza virusspecific (H-2Db/GP33+ and H-2Db/NP366+) CD8 T cells present in the BAL fluid (Figure
9D) and lung parenchyma (Figure 9E,F) by d7 post-infection. In contrast, the total
number of influenza virus-specific CD8 T cells present in these tissues was significantly
reduced in ABX-treated mice (Figure 9D-F). In addition to an impaired CD8 T cell
response, ABX-treated mice exhibited lower titers of PR8-specific IgM and IgG in the
serum at d12 post-infection (Figure 9G). Collectively, these data demonstrate diminished
humoral and cell-mediated adaptive immune responses to influenza virus infection in
ABX-treated mice that correlates with impaired viral clearance from the lung and
increased host susceptibility.
Expression of activation markers such as CD69, CD25, and the cytotoxic granulated
protein Granzyme-B is rapidly upregulated early following acute viral infection and then
downregulated as the infection is controlled (Harty et al., 2000; Lawrence and Braciale,
2004; Wherry et al., 2007). The expression of these molecules on DbGP33 tetramer+
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CD8 T cells (Figure 10A) at day 7, 10, and 12 p.i was assessed for an in depth
phenotypic profile of the CD8 T cell activation over the course of influenza virus infection
(Figure 10B). While DbGP33 tetramer+ CD8 T cells from CNV mice downregulated early
activation markers between d7 to 12 post-infection, expression of CD69 and CD25
remained elevated in DbGP33 tetramer+ CD8 T cells isolated from ABX-treated mice
(Figure 10, Table 1). Elevated expression of these molecules, along with Granzyme-B
and CD43, persisted on influenza virus-specific CD8 T cells isolated from the lung of
ABX-treated mice at d12 post-infection. These data are consistent with a delay in the
adaptive immune response to influenza virus and sustained activation of virus-specific
CD8 T cells due to prolonged viral persistence.

2.4.4 ABX-treated mice exhibit an impaired CD8 T cell response and rapidly
succumb to the weakly pathogenic X31-GP33 influenza A virus.
Infection with the PR8 strain of influenza virus results in substantially increased morbidity
and impaired viral clearance in ABX-treated mice compared to CNV mice, making
comparisons of the functional quality of the CD8 T cell response at a particular timepoint
challenging. To better study the influenza virus-specific CD8 T cell response in ABXtreated mice, CNV or ABX-treated mice were infected with X31-GP33 virus (H3N2
strain), a less pathogenic strain of influenza virus that causes minimal morbidity and
mortality in CNV mice (Bouvier and Lowen, 2010; Decman et al., 2010). Despite
infection with a less virulent influenza virus strain, ABX-treated mice still exhibited
increased weight loss (Figure 11A), elevated viral titers (Figure 11B), increased epithelial
degeneration (Figure 11D) and increased mortality (Figure 11C) following exposure to
X31-GP33 virus compared to CNV mice. X31-gp33 virus-infected CNV mice exhibited
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robust adaptive immune responses by d7 post-infection characterized by large
population of influenza virus-specific CD8 T cells in the BAL fluid (Figure 12A), lung
parenchyma (Figure 12B), mediastinal lymph nodes (Figure 12C) and spleen (Figure
12D) Further, following ex vivo stimulation with GP33 peptide infiltrating virus-specific
CD8 T cells in the lung were capable of simultaneously producing multiple effector
molecules (IFN-γ, TNF-α, IL-2, Mip-1α, CD107a) (Figure 12E). In contrast, ABX-treated
mice exhibited a significant reduction in the number of influenza virus-specific CD8 T
cells isolated from multiple compartments (Figure 12A-D) and these virus-specific T cells
were less capable of simultaneously producing multiple effector molecules indicating a
functionally impaired virus-specific CD8 T cell response in ABX-treated mice. (Figure
12E). Thus, following infection with two separate strains of influenza virus, ABX-treated
mice exhibited a diminished influenza virus-specific CD8 T cell response that correlated
with impaired viral clearance and increased host mortality.

2.4.5 Impaired innate antiviral immune responses in ABX-treated mice
The impaired antiviral CD8 T cell response in ABX-treated mice following either PR8GP33 or X31-GP33 virus infection suggested a potential defect in the early innate
immune response. To test this hypothesis, the recruitment and activation of early
responding innate immune cells was assessed at d3 following PR8-GP33 virus infection.
There was a comparable influx of macrophages, inflammatory monocytes, neutrophils,
plasmacytoid dendritic cells (Figure 13A), and conventional dendritic cells (Figure 13B)
into the lung of CNV versus ABX-treated mice. Further, conventional dendritic cells
exhibited a similar activation profile in CNV versus ABX-treated mice at d3 post-infection
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(Figure 13C). These data suggested that recruitment of innate immune cells and
upregulation of costimulatory molecules was intact in the ABX-treated mice.
The cytokine environment in the lung early following viral infection is a critical factor
that shapes the quality of the adaptive immune response (McGill et al., 2009; Sanders et
al., 2011), therefore the cytokine milieu in CNV or ABX-treated mice prior to and early
following infection was assessed. IL-10 is an immunoregulatory cytokine that has been
demonstrated to influence the antiviral immune response (Brooks et al., 2006; McKinstry
et al., 2009; Sun et al., 2009; Zajac et al., 1998) and expression of this cytokine can be
modulated by the microbiota (Amaral et al., 2008; Mazmanian et al., 2008; Ueda et al.,
2010).

However,

assessment

of

IL-10/eGFP

reporter

Vertex

mice

following

administration of antibiotics revealed no significant differences in the frequency of IL10/eGFP+ macrophages, dendritic cells, CD4 T cells, CD8 T cells, or B cells isolated
from the lung parenchyma (Figure 14A) or spleen (Figure 14B) of CNV versus ABXtreated mice. Further, no difference in mRNA expression of Il10 was observed in the
spleen (Figure 14C) or lung (Figure 14D) of C57BL/6 CNV versus ABX-treated mice. In
addition, following influenza virus infection, a similar increase in IL-10 was detected in
the BAL fluid of CNV versus ABX-treated mice (Figure 14E). Combined, these analyses
indicate that impaired antiviral immune responses in ABX-treated mice were not
associated with dysregulated IL-10 production prior to or following influenza virus
infection. In contrast, reduced levels of proinflammatory cytokines and chemokines were
detected in the BAL fluid of ABX-treated mice early following influenza virus infection
(Figure 15A). Induction of these proinflammatory chemokines and cytokines are critical
to the propagation of the innate immune response and suggest that the functional quality
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of the innate immune response to respiratory viral infection is impaired following ABXmediated alterations in commensal bacteria.

2.4.6 Diminished induction of IFN responsive genes and protection against
influenza virus challenge following restoration of IFN responsiveness in ABXtreated mice
While there was no difference in the total numbers of innate immune cells that
accumulated in the lung, less proinflammatory cytokines and chemokines were present
following influenza virus infection in ABX-treated mice compared to CNV mice (Figure
13, 15). This observation lead to the hypothesis that the quality of the innate antiviral
response was impaired in ABX-treated mice. To test the magnitude of the innate
immune response, mRNA expression of key antiviral defense genes in the lung was
assessed early following influenza virus infection. Despite a similar number of innate
immune cells present in the lung between CNV and ABX-treated mice, there was
significantly reduced expression of interferon-related antiviral defense genes (Ifnb, Irf7,
Mx1, Oas1a, Il28b [Ifnλ], Il6, Tnfa, Ccl3 [Mip1α] and Il1b) in ABX-treated mice compared
to CNV mice at d3 post-infection (Figure 15B). Combined, the decreased expression of
proinflammatory cytokines and antiviral defense genes demonstrate a diminished innate
immune response in ABX-treated mice following influenza virus infection.
Diminished expression of these macrophage-associated interferon response genes
suggested an impaired macrophage response in ABX-treated mice following viral
infection. Alveolar macrophages are resident immune cells in the lung and are among
the first immune cells to encounter influenza virus in the respiratory tract (McGill et al.,
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2009). The response of these cells is crucial for the rapid induction of immune defense
mechanisms (Peschke et al., 1993; Tumpey et al., 2005). To assess the quality of the
macrophage response following influenza virus infection, alveolar macrophages were
sorted from d3 post-infection CNV or ABX-treated mice and assessed for expression of
key antiviral defense genes (Figure 16A). At d3 post-infection alveolar macrophages
from ABX-treated mice had a reduced induction of interferon response genes such as
Mx1, Irf7, Stat1, Ifit3 and Ifnb (Figure 16B). These results identify macrophages as an
innate cell type that exhibits a diminished antiviral immune response to influenza virus
infection following antibiotic-mediated perturbation of commensal bacterial communities.
Combined, these findings demonstrate that ABX-mediated alterations in commensal
bacteria result in impaired induction of innate antiviral defense mechanisms following
respiratory viral infection.
To test whether if restoring the IFN response in ABX-treated mice could provide
protective immunity to influenza virus infection, the synthetic TLR ligand poly I:C, known
to stimulate endogenous type I IFN production (Proietti et al., 2002), was administered to
ABX-treated mice 1 day prior to and 3 days following influenza virus infection. ABXtreated mice receiving PBS had drastic weight loss (Figure 17A), loss of lung function
(Figure 17B) and high mortality following influenza virus infection (Figure 17C). In
contrast, administration of poly I:C to influenza virus infected ABX-treated mice resulted
in less weight loss (Figure 17A) as well as marked improvements in lung function and
survival (Figure 17B,C), suggesting that re-calibrating the immune response to IFN
stimulation could overcome the need for commensal bacteria-derived signaling in
mounting an efficient immune response to influenza virus infection.
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2.5 Discussion
This chapter demonstrates that antibiotic-mediated disruption of commensal bacterial
communities impairs host protective antiviral immunity. Following mucosal-associated
influenza virus infection ABX-treated mice exhibited an impaired innate and adaptive
immune response. Impaired antiviral immunity was characterized by diminished
induction of antiviral defense genes by alveolar macrophages, fewer virus-specific CD8
T cells, reduced circulating viral-specific antibodies and elevated viral titers. Consistent
with a role for commensal bacteria-derived signals in promoting protective antiviral
immunity, commensal bacteria-depleted hosts exhibited severe bronchiole epithelial
degeneration, impaired oxygen exchange and increased mortality following influenza
virus infection. Protective immunity was partially restored in ABX-treated mice by
administering the TLR ligand poly I:C to boost the diminished type I IFN response
observed in ABX-treated mice. These data provide evidence of a role for commensal
bacteria in modulating the immune response to an ongoing viral infection in a tissue
distal to the intestinal tract. It is unclear, however, whether commensal bacteria-derived
signals can only influence the immune response to mucosal-associated viruses that
infect tissues in close proximity to resident bacterial communities or if these signals
influence the systemic immune response against viruses that infect multiple peripheral
tissues. This question will be addressed in Chapter 3.
In a recent report Iwasaki and colleagues also observed that deliberate manipulation of
commensal bacteria resulted in impaired antiviral immunity in the lung (Ichinohe et al.,
2011). This defect was associated with decreased expression of genes involved in the
inflammasome pathway in the lung of antibiotic-treated mice compared to CNV mice
following influenza virus infection (Ichinohe et al., 2011). While our studies also observed
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decreased Il-1b mRNA expression in whole lung tissue following infection, alveolar
macrophages isolated from CNV or ABX-treated mice did not exhibit significant
differences in expression of inflammasome related genes such as Il-1b, ll-18, and Nlrp3
(data not shown). Instead, alveolar macrophages isolated from ABX-treated mice
exhibited significantly reduced expression of antiviral interferon response genes such as
Mx1 and Oas1a, suggesting a novel interplay between commensal bacteria and
interferon signaling pathways that are critical in response to most viruses. Further, two
recent reports have identified a fundamental interaction between the intestinal microbiota
and enteric viruses where the virus utilizes the presence of commensal bacteria to
enhance infectivity of the gastrointestinal tract (Kane et al., 2011; Kuss et al., 2011).
Antibiotic treatment did not alter influenza virus infectivity of the respiratory mucosa in
our studies suggesting that enteric and respiratory viruses have evolved different
mechanism to promote replication. Collectively, these reports highlight the dynamic
interrelationship between viral pathogens, commensal bacteria and the immune system
and support a model where commensal bacteria-derived signals can coordinately
influence multiple innate immune cell types to impact the immune response in the lung in
an infection setting. Further these data provoke the possibility that commensal bacteria
may provide tonic stimulation on innate immune cells prior to infection, thereby
predisposing the immune system to rapidly respond to pathogens upon initial encounter.
This hypothesis will be the focus of Chapter 4.
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Figure 5. Oral antibiotic treatment alters commensal bacterial communities in the
intestine and upper respiratory tract, but not immune cell populations in the lung.
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Figure 5. Culturable bacteria from (A) stool samples or (B) trachea homogenates of naïve
CNV or ABX‐treated mice following two weeks of antibiotic treatment. Samples were plated
on (A) Schaedler’s or (B) LB agar and incubated for 48hrs in aerobic or anaerobic conditions
(L.o.D., limit of detection). (C) H&E stained lung sections from naïve CNV or ABX‐treated mice
(scale bar: 200µm). (D) Total number of hematopoietic cells in the lung parenchyma of CNV
or ABX‐treated mice at steady‐state. Cells quantified by flow cytometric analysis. CD4 T cells
gated on CD45+, CD3ε+, CD4+. CD8 T cells gated on CD45+, CD3ε+, CD8α+. B cells gated on
CD45+, CD19+, MHC‐IIhi. Alveolar macrophages gated on CD45+, NTNB, CD11c+, F4/80+.
Neutrophils gated on CD45+, NTNB, CD11b+, Ly6g+. Monocytes gated on CD45+, NTNB,
CD11b+, Ly6c+. Dendritic cells gated on CD45+, NTNB, F4/80‐, Ly6g‐, CD11c+, MHC‐IIhi. NK cells
gated on CD45+, NTNB, NK1.1+. Eosinophils gated CD45+, NTNB, F4/80‐, SSChi, Siglec‐F+.
Plasmacytoid dendritic cells gated on CD45+, NTNB, non‐alveolar macrophage, non‐
neutrophil, non‐monocyte, CD11cint, PDCA‐1+. Data representative of three independent
experiments n = 3‐5 mice per group. Data shown are the mean ± SEM. **p <0.01.
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Figure 6. ABX-treated mice have a higher morbidity and mortality rate following
influenza virus infection.

Figure 6. CNV or ABX‐treated C57BL/6 mice were infected intranasally (i.n.) with 368 TCID50
recombinant influenza virus PR8‐GP33. Timecourse of (A) weight loss and (B) blood oxygen
saturation following infection (representative exp. n=5: † signifies mice below 70% initial
weight were sacrificed). (C) Influenza virus genome copies in the lung at d12 post‐infection
assessed by qPCR and displayed as TCID50/gram of lung tissue based on a standard curve of
genome copies versus TCID50 (L.o.D., limit of detection). (D) Survival curve following PR8‐
GP33 infection. Survival curve is a combination of five independent experiments; CNV n=27,
ABX n=25. Data representative of five independent experiments with n=5‐6 mice per group.
Survival statistics determined by logrank test. Viral titer statistics determined by two‐part t‐
test. *p<0.05, **p <0.01, ***p<0.001.
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Figure 7. ABX-treated mice exhibited increased lung pathology following
influenza virus infection.
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Figure 7. H&E stained lung section of (A,B) CNV or (C‐F) ABX‐treated mice at d12 post‐
infection. Black box/arrows highlight (A,B) epithelial hyperplasia, (C,D) epithelial cell
necrosis, (E) cellular debris and exudate in lumen and (F) loss of bronchiole epithelium (scale
bar: 50µm A,C,E,F; 20µm B,D). (G) Disease score of bronchiole epithelial degeneration at d12
post‐infection. (H) Flow cytometric analysis and (I) frequency of dead cells in the BAL fluid of
CNV or ABX‐treated at d12 post‐infection as assessed by an amine reactive viability dye. Data
representative of three independent experiments with n=5 mice per group. Data shown are
the mean ± SEM. **p <0.01.
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Figure 8. GF mice have increased morbidity, impaired viral clearance and
exacerbated lung pathology following influenza virus infection.

Figure 8. CNV, ABX‐treated or GF C57Bl/6 mice were infected i.n. with 368 TCID50
recombinant influenza virus (PR8‐GP33 strain). (A) Timecourse of weight loss following
infection. (B) Influenza virus genome copies in the lung at d12 p.i. assessed by qPCR and
displayed as TCID50/gram of lung based on a standard curve of genome copies versus TCID50
tissue. (C) PR8‐specific IgM and IgG titers in serum at d12 post‐infection. H&E stained lung
sections of (D) CNV, (E) ABX, or (F) GF mice at d12 post infection. Black arrows highlight
bronchiole epithelial necrosis/loss (scale bar: 50µm). Data representative of two
independent experiments with n=5 mice per group. Viral titer statistics determined by two‐
part t test. Data shown are the mean ± SEM. *p<0.05, ** p <0.01.
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Figure 9. ABX-treated mice exhibit a diminished adaptive immune response
following influenza virus infection.

Figure 9. (A) H&E stained lung sections demonstrate lymphocyte infiltration into alveolar
spaces at day 7 p.i. (scale = 200µm) (B) Total number of T cells in the lungs and (C) BAL fluid
at day 7 p.i. (D‐F) Total number of influenza virus‐specific DbGP33 tetramer+ CD8 T cells
isolated from the (D) BAL fluid or (E) lung parenchyma at d7 post‐infection. (F) DbNP366
tetramer+ CD8 T cells isolated from the lung parenchyma at d7 post‐infection. (G) PR8‐
specific IgM and IgG titers in the serum at d12 post‐infection. Data representative of three
independent experiments with n=4‐5 mice per group. Data shown are the mean ± SEM.
*p<0.05, **p< 0.01.
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Figure 10. Influenza virus-specific CD8 T cells have an altered phenotype in ABXtreated mice that correlates with impaired activation.
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Figure 10. Phenotypic profile of DbGP33 tetramer+ CD8 T cells isolated from the lung of CNV
(black line) or ABX‐treated (red line) mice at d7,10,12 post‐infection. Gray shaded histograms
are CD44lo CD8 T cells isolated from the lung. Numbers in italics represent MFI. Data
representative of three independent experiments with n=4‐5 mice per group. *p<0.05, **p<
0.01.
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Table 1. Expression of activation markers on influenza virus-specific CD8 T cells.

Table 1. Frequency of DbGP33 tetramer+ CD8 T cells that express CD69, CD25, Granzyme‐b,
CD43 or CXCR3 at d7, 10, or 12 post influenza virus infection (PR8‐GP33 strain). Positive gate
determined by expression of markers on naïve CD44lo CD62Lhi, CD8 T cells. Data shown are
the mean ± SEM. *p<0.05, **p<0.01, ***p<0.001.
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Figure 11. ABX-treated mice are susceptible to weakly pathogenic X31-gp33
influenza virus strain.

Figure 11. CNV or ABX‐treated C57Bl/6 mice were infected i.n. with 1x105 TCID50 recombinant
influenza virus X31‐GP33. (A) Timecourse of weight loss following infection. (B) Influenza
virus genome copies in the lung at d7 post‐infection assessed by qPCR and displayed as
TCID50/gram of lung tissue based on a standard curve of genome copies versus TCID50. (C)
Survival curve following infection. (D) H&E stained lung section of CNV or ABX lungs at d7
post‐infection (black arrow highlights epithelial necrosis/loss; scale 20µm). Data
representative of three independent experiments with n=4‐5 mice per group. Survival curve
statistics determined by logrank test. Viral titer statistics determined by two‐part t‐test.
*p<0.05, **p <0.01, ***p<0.001.
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Figure 12. Diminished and functionally impaired influenza virus-specific CD8 T
cell response in ABX-treated mice following X31 virus infection.
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Figure 12. Total number of DbGP33 tetramer CD8 T cells in the (A) BAL, (B) lung, (C)
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mediastinal lymph nodes, and (D) spleen at d7 post‐infection. (E) Lung cells were stimulated
Sample

with GP33 peptide for 5hrs in the presence of BFA. Proportion of GP33 peptide responsive
CD8 T cells in the lung producing multiple effector molecules (IFN‐γ, TNF‐α, IL‐2, MIP‐1α,
CD107a). Data representative of three independent experiments with n=4‐5 mice per group.
Data shown are the mean ± SEM. *p<0.05, **p <0.01, ***p<0.001.
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Figure 13. Recruitment and activation of innate immune cells in the lung is
equivalent in CNV and ABX-treated mice following influenza virus infection.
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Figure 13. (A) Total numbers of alveolar macrophages, inflammatory monocytes, neutrophils
and plasmacytoid dendritic cells (pDC) isolated from BAL fluid at d3 post‐infection. Alveolar
macrophages gated on CD3ε‐, CD5‐, CD19‐, NK1.1‐ (Non T, Non B, Non NK cells ‐ NTNBNNK),
CD11c+, F4/80+. Inflammatory monocytes gated on NTNBNNK, CD11c‐, F4/80‐, Ly6g‐, Ly6c+,
CD11b+. Neutrophils gated on NTNBNNK, CD11c‐, F4/80‐, Ly6g+, CD11b+. pDC gated on
NTNBNNK, non‐alveolar macrophage, non‐neutrophil, non‐inflammatory monocyte, CD11cint,
PDCA‐1+. (B) Total numbers of dendritic cells (DCs) isolated from the lung parenchyma and
mediastinal lymph node (medLN). DCs are gated on NTNBNNK, F4/80‐, CD11c+, MHC‐IIhi cells.
(C) Expression of CD86 and CD40 on naïve or d3 post‐infection DCs isolated from the lung
and medLN of CNV or ABX‐treated mice. Data representative of four independent
experiments with n=3‐5 mice per group. Data shown are the mean ± SEM.
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Figure 14. Equivalent IL-10 expression in CNV and ABX-treated mice at steadystate and following influenza virus infection.

Figure 14. Frequency of the IL‐10 competent immune cells in the (A) lung, or (B) spleen of
naïve, CNV or ABX‐treated IL‐10/eGFP reporter Vertex mice. B cells were gated on live,
CD45+, CD19+, MHC‐IIhi. CD4 T cells were gated on live, CD45+, CD3ε+, CD4+. CD8 T cells were
gated on live, CD45+, CD3ε +, CD8+. Dendritic cells were gated on live, CD45+, CD3ε‐, CD5‐,
CD19‐ (Non‐T, Non‐B ‐ NTNB) CD11c+, MHC‐IIhi. Splenic macrophages from the spleen were
gated on live, CD45+, NTNB, CD11b+, F4/80+. Alveolar macrophages were gated on live,
CD45+, NTNB, CD11c+, F4/80+. (C,D) Relative expression of Il‐10 mRNA in the (C) spleen or (D)
lung of naïve CNV or ABX‐treated mice. (E) IL‐10 protein present in the BAL fluid of influenza
virus infected CNV or ABX‐treated mice (PR8‐GP33). IL‐10 levels determined by luminex
multiplex bead array. Statistical analysis of individual timepoints was done by Student’s t‐
test. Data representative of two independent experiments with n=3‐5 mice per group. Data
shown are the mean ± SEM. *p<0.05, **p<0.01.
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Figure 15. Diminished induction of antiviral defense genes and proinflammatory
cytokines in the lung of ABX-treated mice at D3 following influenza virus
infection.

A

BAL fluid

0

120

0

N D3 N D3

CNV ABX

N D3 N D3

125

0

CNV ABX

N D3 N D3

0

IP-10

p=0.07

400

CNV ABX

MCP-1

1.5

800

0.75

N D3 N D3

CNV ABX

0

400

0

N D3 N D3

CNV ABX

N D3 N D3

CNV ABX

Lung - D3

B

(over CNV naïve)

1200

Fold increase

MIP-1"
800

pg/mL

MIP-1!
250

ng/mL

1

TNF-!
*

pg/mL

pg/mL

ng/mL

240

pg/mL

IL-6
*

2

Ifnb
*

70

Irf7
*

Mx1
120

75

Oas1a
*

600

Ifn!
**

500

Il6
*

120

Tnfa
*

Il1b
14

50
600

60

35

250

300

60

7

25

0

CNV ABX

0

CNV ABX

0

CNV ABX

0

CNV ABX

0

0
CNV ABX

0

CNV ABX

0

CNV ABX

0

CNV ABX

Figure 15. (A) Proinflammatory cytokines and chemokines present in BAL fluid d3 post
influenza virus infection. (B) Fold induction of antiviral defense gene expression in the lung at
d3 post‐influenza virus infection compared to lung of naive CNV mice as assessed by qPCR.
Data representative of two or more independent experiments with n=3‐5 mice per group.
Data shown are the mean ± SEM. *p< 0.05, **p<0.01.
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Figure 16. Alveolar macrophages from influenza virus infected, ABX-treated mice
exhibit diminished expression of antiviral defense genes.
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Figure 16. CNV or ABX‐treated mice were infected with influenza virus (PR8‐GP33). At d3
post‐infection, alveolar macrophages (NTNBNNK, F4/80+, CD11c+) were sorted from the BAL
and RNA was purified to assess in vivo induction of antiviral defense genes by qPCR. (A)
Representative FACS plot demonstrating pre & post‐sort purity of alveolar macrophages.
FACS plots gated on CD45+ cells. (B) Gene expression displayed as fold induction over naïve
alveolar macrophages from CNV mice. Data representative of two independent experiments
with n=3‐5 mice per group. Data shown are the mean ± SEM. *p <0.05, **p<0.01.
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Figure 17. Restoration of IFN responsiveness partially protects ABX-treated mice
against influenza virus challenge.

Figure 17. CNV or ABX‐treated mice were infected with influenza virus (PR8‐GP33). Mice
received 30µg of poly I:C (ABX+pIC group) or PBS (CNV & ABX group) i.n. at d ‐1 and 100µg of
poly I:C or PBS i.p. at d3. (A) Weight loss and (B) blood oxygen saturation following infection
(representative exp. n=4‐6: † signifies mice below 70% initial weight were sacrificed). Weight
loss statistics determined by two‐way ANOVA comparing ABX+pIC to ABX (p<0.01) or CNV to
ABX (p<0.01). (C) Survival curve following influenza virus infection. Survival curve is a
combination of 2 independent experiments. CNV n=10, ABX n=8, ABX+pIC n=12. Survival
statistics determined by logrank test comparing ABX+pIC to ABX (p<0.05) or ABX+pIC to CNV
(p=0.12). *p <0.05, **p<0.01.
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Chapter 3
Commensal bacteria-derived signals augment innate and
adaptive immune responses following systemic viral infection
3.1 Abstract
Commensal bacterial communities can modulate intestinal immune homeostasis and
response to infection in the gastrointestinal tract. Data presented in Chapter 2
demonstrated a role for commensal bacteria-derived signals in promoting the antiviral
immune response to a localized respiratory viral infection (influenza virus). Whether
commensal bacteria-derived signals influence immunity to systemic viral infection,
however, remains poorly defined. To test this, CNV or ABX- treated mice were infected
with Lymphocytic Choriomeningitis Virus (LCMV) and the induction and quality of the
innate and adaptive immune responses were analyzed. Macrophages isolated from
ABX-treated mice exhibited lower expression of co-stimulatory molecules and impaired
activation the type I interferon (IFN) signaling pathway. The diminished innate immune
response was associated with a defective adaptive immune response. ABX-treated mice
exhibited a functionally impaired LCMV-specific CD8 T cell response and delayed
control of viral replication compared to CNV control mice. Collectively, these studies
indicate that signals derived from commensal bacteria aid in the induction of a rapid
antiviral immune response required for immunity to systemic viral infection.
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3.2 Introduction
Intestinal commensal bacteria are important in the development and homeostasis of the
GALT (Artis, 2008; Macpherson and Harris, 2004). Immunologic analysis of mice that
were reared in the absence of live commensal bacteria (GF mice), highlight the
significance of the relationship between commensal bacterial communities and the
intestinal immune system. For example, the Peyer’s patches and mesenteric lymph
nodes of GF mice are reduced in cellularity and fewer CD4 and CD8 T cells reside in the
intraepithelial compartment compared to CNV control mice (Glaister, 1973) (Macpherson
and Harris, 2004). In addition to developmental defects, loss of commensal bacteriaderived signaling impacts intestinal immune cell homeostasis and inflammation, altering
immune cell differentiation, migration, and antibody production (Ivanov et al., 2008;
Macpherson and Uhr, 2004; Niess and Adler, 2010; Obata et al., 2010; Round and
Mazmanian, 2010). Several murine models of spontaneous intestinal inflammation, in
part characterized by overproduction of proinflammatory cytokines in the intestinal
microenvironment, exhibit amelioration of disease when re-derived in a sterile, germ-free
environment (Dianda et al., 1997; Schultz et al., 1999; Sellon et al., 1998). Collectively,
these studies demonstrate a fundamental relationship between commensal bacteria and
the intestinal immune system.
However, whether commensal bacteria-derived signals shape the systemic immune
system, which is not in direct contact with commensal bacteria that reside at barrier
surfaces of the body, is less well characterized. GF mice have fewer germinal centers
and plasma cells in the spleen supporting a role for commensal bacteria in immune
development beyond the GALT (Macpherson and Harris, 2004). It has also been
reported that the commensal specie Segmented Filamentous Bacteria can impact
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disease progression in murine models of autoimmune inflammatory disorders such as
arthritis, multiple sclerosis and diabetes (Ivanov et al., 2009; Kriegel et al., 2011; Lee et
al., 2011; Wu et al., 2010b), suggesting that commensal bacterial communities can have
an impact on systemic inflammatory responses. It is unknown, however, whether
commensal bacteria-derived signals help shape the systemic immune response to a
pathogen that infect multiple tissues throughout the host. This chapter addresses the
impact of commensal bacteria-derived signals on the host immune response to a
systemic pathogen, Lymphocytic Choriomeningitis Virus (LCMV).
Unlike influenza virus, which was employed in studies described in Chapter 2, LCMV
is a non-cytolytic virus that can infect multiple organs, such as the spleen, liver, kidney,
lung as well as the gastrointestinal tract (Buchmeier et al., 1980; Sydora et al., 1996).
Infection can result in a chronic viremia if not efficiently controlled by the antiviral
immune response with viral reservoirs persisting at immuno-privileged sites such as the
CNS and kidney (Ahmed et al., 1987; Ahmed et al., 1984b; Zajac et al., 1998). LCMV
infection elicits a potent CD8 cytotoxic T lymphocyte (CTL) response that is crucial for
viral control through the production of proinflammatory cytokines (e.g. TNF-α and IFN-γ)
and cell-mediated cytotoxicity (Ahmed et al., 1984a; Kaech et al., 2002; Welsh et al.,
1990). Dendritic cells and macrophages of the innate immune system are critically
important in the priming and expansion of the LCMV-specific CD8 T cell response via
antigen

presentation,

co-stimulatory

molecule

interaction,

and

production

of

proinflammatory cytokines such as type I IFNs that provide a 3rd signal to initiate T cell
activation (Belz et al., 2005; Cousens et al., 1999; Montoya et al., 2005; Oehen et al.,
2002; Seiler et al., 1997). In this chapter, we demonstrate that following LCMV infection
mice depleted of commensal bacteria exhibit a functionally defective LCMV-specific CD8
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T cell response that correlates with delayed control of viral replication. Compared to
CNV mice, ABX-treated mice exhibited diminished induction of innate proinflammatory
cytokines

and

antiviral

defense

genes

early

following

infection.

Specifically,

macrophages from ABX-treated mice exhibited an impaired response to type I IFN
signaling and a diminished activation profile. Thus, commensal bacteria-derived signals
are critical in the intiation of the early innate immune response to systemic viral infection.
Lack of sufficient commensal bacteria-derived signaling lead to downstream defects in
the adaptive immune response and ultimately an inability to control viral infection.

3.3 Methods
3.3.1 Mice and viruses
C57BL/6 mice (4-6 weeks old) were purchased from the National Cancer Institute
(Frederick, MD). Mice were maintained in specific pathogen–free facilities at the
University of Pennsylvania. The University of Pennsylvania Institutional Animal Care and
Use Committee (IACUC) approved all protocols, and all experiments were performed
according to the guidelines of the University of Pennsylvania IACUC. Mice were
inoculated intravenously (i.v.) with LCMV T1b (4x106 PFU). LCMV viral titers were
determined by plaque assay on Vero cell monolayers (Ahmed et al., 1984b).
3.3.2 Oral antibiotic treatment
Mice were provided autoclaved drinking water supplemented with ampicillin (0.5 mg/mL,
Sigma), gentamicin (0.5 mg/mL, Gemini Bio-Products), metronidazole (0.5 mg/mL
Sigma), neomycin (0.5 mg/mL, Med-Pharmex), vancomycin (0.25 mg/mL, Novaplus),
and sucralose (4mg/mL, Splenda, McNeil Nutritionals, LLC). Splenda was added to
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make the antibiotic cocktail more palatable. Antibiotic treatment was started 2-4 weeks
prior to infection and continued for the duration of the experiment.
3.3.3 Isolation of cells and flow cytometric staining
Lymphocytes were isolated from the spleen or lymph node by mechanical disruption
through 70µm cell strainers followed by red blood cell (RBC) lysis. Peripheral blood
mononuclear cells (PBMCs) were isolated using a Histopaque gradient (Sigma).
Peritoneal exudates cells (PECs) were obtained by injecting and recovering PBS from
the peritoneal cavity. Single cell suspensions were surface stained in FACS Buffer (PBS,
2% BSA, 0.2mg Sodium Azide, 2mM EDTA) using standard flow cytometric staining
protocols with fluorescently conjugated antibodies specific to CD3ε, CD4, CD8α, CD11c,
CD19, CD25, CD43, CD45, CD69, CD160, F4/80, Ly6c, MHC-I (H-2Kb), MHC-II (I-A/I-E)
(eBioscience), CD5, CD44, CD80, CD86, Ly6g (clone 1A8), ICOS, LAG-3, PD-1 (clone
RMP1-30) (Biolegend), CD40 (BD Biosciences), CXCR3 (R&D Systems), 2B4 (BD
Pharmingen), CD11b, and granzyme B (Invitrogen). Major histocompatibility complex
(MHC) class I peptide tetramers were made and used to identify virus-specific CD8 T
cells (Altman et al., 1996). For intracellular cytokine analysis, 106 splenocytes were
cultured in a 96-well plate in complete media with viral peptides (0.2 µg/ml) and brefeldin
A (Golgiplug, eBioscience) for 5 hrs at 37°C. After staining for surface antigens as
described above, cells were stained for intracellular cytokines using the
Cytofix/Cytoperm kit (BD Pharmingen) and fluorescently conjugated antibodies specific
for IL-2 (eBioscience), IFN-γ (BD Pharmingen), TNF-α (Biolegend), MIP-1α (R&D
Systems). The CD107a assay was performed as previously described (Blackburn et al.,
2009). Cell viability was assessed with Live/Dead AQUA stain (Invitrogen). Samples
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were collected by using a LSR II flow cytometer (Becton Dickinson). All flow cytometry
data was analyzed by FlowJo v 8.8 (Treestar). Pie charts were created using the Pestle
and SPICE programs (Mario Roederer; Vaccine Research Center, NIAID, NIH).

3.3.4 Virus-specific antibody and cytokine ELISA
LCMV-specific IgM and IgG serum antibody concentrations were determined by ELISA
as previously described (Ahmed et al., 1984b; Mozdzanowska et al., 2000). In brief,
LCMV was adsorbed to plates and bound antibody was detected using anti-IgM or -IgG
conjugated to alkaline phosphatase (Sigma) and developed with p-nitrophenol
phosphate (Sigma). Optical densities (OD405-750) were measured using an ELISA reader
and concentrations calculated using SoftMax Pro software (Molecular Devices). Serum
samples were analyzed for cytokines and chemokines by luminex multiplex bead array
(Millipore). Tissue from the spleen was mechanically homogenized in DMEM,
centrifuged, and the resultant supernatant was measured for cytokine secretion by
ELISA (eBioscience). IFN-β protein levels in the serum or spleen homogenates were
measured by ELISA (PBL Interferonsource).
3.3.5 RNA isolation, cDNA preparation, and RT-PCR
RNA was isolated from cells using an RNeasy mini-kit (Qiagen) and from spleen tissue
using mechanical homogenization and TRIzol isolation (Invitrogen) according to the
manufacturer’s

instructions.

cDNA

was

generated

using

SuperScript

reverse

transcriptase (Invitrogen). RT-PCR was performed on cDNA using SYBR green
chemistry (Applied Biosystems) and commercially available primer sets (Qiagen).
Reactions were run on an RT-PCR system (ABI7500; Applied Biosystems). Genes of
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interest were normalized to hypoxanthine guanine phosphoribosyl transferase (Hprt) and
displayed as fold difference relative to uninfected CNV control mice.
3.3.6 In vivo Phosflow STAT1 staining following LCMV infection
LCMV-infected CNV or ABX-treated mice were sacrificed at 6 or 12 hrs post-infection.
Cells were immediately fixed to preserve phosphorylation status as described in (Krutzik
et al J.I. 2005). Briefly, cells were directly resuspended in DMEM w/ 1.6% PFA.
Following a 10 minute incubation at room temperature, cells were centrifuged and
resuspended in 90% methanol for 30 minutes at 4 oC then washed 3x with FACS buffer
followed by staining with surface markers and pSTAT1 with PE-conjugated anti-STAT1
(pY701) antibody (BD biosciences).
3.3.7 Statistical analysis
Results represent means ± SEM. Statistical significance was determined by the
unpaired, two tailed, Student’s t-test for individual timepoints, two-way ANOVA test for
timecourse experiments, logrank test for survival curve, or two-part t-test for comparison
of groups that contained samples that were below the limit of assay detection. Statistical
analyses were performed using Prism GraphPad software v4.0. (*p < 0.05; **p < 0.01;
***p < 0.001).
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3.4 Results
3.4.1 Diminished adaptive immune response and delayed clearance of LCMV
following ABX-mediated depletion of commensal bacteria
Signals from commensal bacteria regulate immune cell homeostasis and susceptibility to
multiple infectious and inflammatory diseases in the gastrointestinal tract (Garrett et al.,
2010b; Honda and Littman, 2012; Round and Mazmanian, 2009). However, it is not clear
whether commensal bacteria-derived signals regulate immunity to pathogens that infect
sites distal to the gastrointestinal tract. To address this question, naïve C57BL/6 mice
were orally administrated broad-spectrum antibiotics for two weeks and subsequently
infected with 2x106 PFU LCMV T1b, a strain of virus that results in viremia for 1-2 weeks
and requires a robust innate and adaptive immune response for viral clearance
(Blackburn et al., 2009; King et al., 1990). Consistent with our earlier studies, exposure
to antibiotics resulted in loss of culturable bacteria from enteric contents, a reduction in
total bacterial 16S rDNA in the intestine and a dramatic reorganization of the commensal
community structure (Figure 18A) (Hill et al., 2010). CNV mice and ABX-treated mice
were longitudinally bled following LCMV infection to assess viral clearance and induction
of virus-specific cellular and humoral adaptive immune cell response. CNV mice
exhibited maximal viremia at day 7 (d7) post-infection and successfully controlled
viremia by d23 (Figure 18B). Control of infection was associated with the population
expansion of LCMV-specific H-2Db gp33+ and H2-Db gp276+ tetramer+ (H-2Db/GP33+
and H-2Db/GP276+) CD8 T cells (Figure 18C,D), the two dominant CD8 T cell epitopes,
as well as the presence of LCMV-specific IgG in the serum (Figure 18E). In contrast,
ABX-treated mice exhibited a significant delay in clearance of LCMV (Figure 18B) that
was associated with a delayed expansion of LCMV-specific CD8 T cell response and
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reduced IgG antibody titers in the serum (Figure 18C-E). Thus, longitudinal bleeds to
monitor a systemic viral infection in mice depleted of commensal microbial communities
revealed a significant defect in the ability to control viremia and mount an adaptive
immune response to LCMV infection in ABX-treated mice.
CNV or ABX-treated mice were sacrificed one month following LCMV infection and
virus-specific immune responses and persisting viral reservoirs in peripheral tissues
were analyzed. At d31 post-infection, ABX-treated mice exhibited increased viral titers in
the kidneys (Figure 19A) that correlated with fewer total numbers of LCMV-specific
tetramer+ (H-2Db/GP33+, H-2Db/GP276+ and H-2Db/NP396+) CD8 T cells in the spleen
(Figure 19C-D). Elevated viral titers and decreased numbers of LCMV-specific CD8 T
cells in ABX-treated mice indicate a significant impaired ability to control systemic viral
infection in ABX-treated mice.

3.4.2 ABX-treated mice exhibit a functionally impaired LCMV-specific CD8 T cell
response
Persisting viral reservoirs and fewer virus-specific CD8 T cells has been closely linked to
functionally impaired CD8 T cell responses (Fuller et al., 2004; Wherry et al., 2005;
Zajac et al., 1998), which can be characterized by a hierarchical increase in expression
of multiple inhibitory receptors and decreased expression of effector molecules,
attributes considered to be hallmarks of CD8 T cell exhaustion (Blackburn et al., 2009;
Wherry et al., 2003). Therefore, LCMV-specific CD8 T cells isolated from the spleen of
CNV or ABX-treated mice were assessed for expression of inhibitory receptors and
effector molecules to measure CD8 T cell function. At d31 post-infection, LCMV-specific
H2-Db/GP33 tetramer+ CD8 T cells isolated from ABX-treated mice expressed increased
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levels of multiple inhibitory receptors PD-1, 2B4, CD160 and LAG-3 compared to H2Db/GP33 tetramer+ CD8 T cells from CNV mice (Figure 20A,B).
Following ex vivo stimulation with viral peptides, cytotoxic CD8 T cells (Figure 21A,B
from CNV mice readily produced effector cytokines such as IFN-γ and TNF-α, critical
effector molecules with potent antiviral properties (Leist et al., 1989; Ramshaw et al.,
1997). In contrast, GP33 responsive CD8 T cells from ABX-treated mice were less
efficient producers of multiple effector molecules (IFN-γ, TNF-α, IL-2, MIP-1α, CD107a)
(Figure 21A,B). To evaluate whether the impaired DbGP33 tetramer+ CD8 T cell
response in ABX-treated mice is indicative of the global LCMV-specific CD8 T cell
response, splenocytes were stimulated with a pool of 20 LCMV-specific peptides (Kotturi
et al., 2007). Following stimulation with pooled LCMV-specific peptide, fewer IFNγ+/TNF-α+ dual producing CD8 T cells were observed in ABX-treated mice compared to
CNV mice (Figure 21C,D) confirming that the functionally impaired response to the
GP33-41 epitope was representative of the total LCMV-specific CD8 T cell response in
ABX-treated mice. Together, these data are consistent with more severe T cell
exhaustion in the ABX-treated group, a characteristic sign of impaired immunity to LCMV
infection (Wherry, 2011; Yi et al., 2010).
In addition, while there was no significant difference in the total number of LCMVspecific I-Ab/GP61 tetramer+ CD4 T cells in the spleen at d31 post-infection (Figure
22A), a significant increase in PD-1 expression on GP61 tetramer+ CD4 T cells was
observed in the spleen ABX-treated mice compared to CNV mice (Figure 22B),
indicating impairment in the quality of the virus-specific CD4 T cell response. Stimulation
of splenocytes with GP61 peptide revealed that fewer GP61 tetramer+ CD4 T cells
isolated from ABX-treated mice produced cytokines (IFN-γ and IL-2) compared to CD4 T
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cells from CNV mice (Figure 22C). Combined, these data indicate that deliberate
manipulation of commensal bacteria-derived signals results in defective virus-specific
adaptive CD4 and CD8 T cell responses and impaired control of viral replication
following systemic infection.
3.4.3 Impaired innate immune response to LCMV infection in ABX-treated mice
Studies discussed in Chapter 2 demonstrated that depletion of commensal bacteria
resulted in reduced adaptive immune responses and impaired viral clearance that
correlated with diminished induction of innate proinflammatory cytokines and antiviral
defense genes early following infection. To determine whether a diminished innate
antiviral response was a generalized phenomenon in ABX-treated mice, expression of
macrophage-associated antiviral response genes and production of proinflammatory
cytokines were examined during LCMV infection. As early as 12 hours post-LCMV
infection significantly reduced expression of mRNA encoding Ifnb, Irf7, Mx1, Oas1a and
Stat1 in the spleen (Figure 23A) and decreased IFN-β in the serum (Figure 23B) was
observed in ABX-treated mice compared to CNV mice. Furthermore, reduced levels of
proinflammatory cytokines were detected in the spleen homogenates of ABX-treated
mice following LCMV infection (Figure 23C), indicating a diminished innate antiviral
responses following systemic viral infection. In addition, expression of costimulatory
molecules on macrophages and dendritic cells from CNV or ABX-treated mice was
assessed as a measure of innate immune activation following infection. Macrophages
isolated from ABX-treated LCMV-infected mice exhibited reduced expression of MHC-I
and CD86 (Figure 23D) and DCs expressed reduced MHC-II and CD86 at d1 postinfection (Figure 23E). Collectively, these findings indicate that ABX-mediated alterations
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in commensal bacteria result in selective dysregulation of innate immune responses
following systemic viral infection.
3.4.4 Impaired in vivo antiviral macrophage response following LCMV in ABXtreated mice
Induction of type I IFNs in response to viral infection is a critical step in initiating early
innate antiviral defense mechanisms (Hwang et al., 1995; Muller et al., 1994). IFN
signaling leads to transcription of antiviral defense genes, the recruitment and activation
of innate immune cells, and aid in the induction of T cell expansion and differentiation
(Ramshaw et al., 1997; Sen, 2001). Diminished activation of innate immune cells and
induction of proinflammatory cytokines in ABX-treated mice early following LCMV
infection suggests defects in the IFN response. STAT1 is a transcription factor
downstream of the IFN receptor signaling pathway (Li et al., 1997). Following IFN
stimulation, STAT1 is phosphorylated, translocates into the nucleus, and initiates
transcription of multiple antiviral defense genes including a positive feedback loop of
more type I IFN production (Schindler et al., 1992; Shuai et al., 1992). Therefore, STAT1
phosphorylation can be used as a bio-marker for IFN signaling. To determine whether
defects in macrophage interferon signaling exist in vivo following viral infection, CNV or
ABX-treated mice were infected with LCMV and the STAT1 phosphorylation status of
innate immune cells in the spleen and peritoneal cavity was assessed by fixing cells
directly ex vivo. This procedure preserves the phosphorylation status of the STAT
protein in the cell as it existed in vivo (Krutzik et al., 2005). As early as 6 hr postinfection, macrophages isolated from the spleen of ABX-treated mice displayed reduced
pSTAT1 compared to splenic macrophages in CNV mice (Figure 24A,B). By 12hr postinfection, peritoneal macrophages from ABX-treated mice had yet to display a significant
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phosphorylation of STAT1 while pSTAT1 induction was detectable in peritoneal
macrophages from CNV mice (Figure 24C,D). These results indicate that antiviral
responses in macrophages from ABX-treated mice following LCMV infection are
impaired in vivo. These data, in combination with the data presented in Chapter 2
identifying diminished expression of antiviral defense genes in alveolar macrophages
isolated from ABX-treated mice following influenza virus infection (Figure 16), suggest a
global defect in macrophage antiviral response in hosts lacking exposure to commensal
bacteria-derived signals.

3.5 Discussion
Commensal bacterial communities can modulate immune cell homeostasis and disease
by providing either immunoregulatory or proinflammatory signals (Round and
Mazmanian, 2009). For example, the microbial product polysaccharide A, isolated from
Bacteroides fragilis, can reduce the severity of intestinal inflammation in two murine
models of IBD (Mazmanian et al., 2008). In addition, Segmented Filamentous Bacteria,
an enteric commensal bacteria induces a CD4+ TH17 cell population in the small
intestine leading to increased susceptibility to autoimmune arthritis and experimental
autoimmune encephalomyelitis (Lee et al., 2011; Wu et al., 2010b), demonstrating that
intestinal bacteria can shape the inflammatory response at sites outside of the local
gastrointestinal environment. These studies provoke the hypothesis that commensal
bacteria-derived signals might influence the systemic immune response to infection.
The results presented in this chapter demonstrate a role for commensal bacterial
communities in influencing the immune response to a systemic viral infection. Antibioticmediated disruption of commensal bacterial communities compromised innate and
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adaptive antiviral immunity following LCMV infection. Severe defects in the adaptive
immune response to LCMV as well as poor control of viral replication pointed toward
early defects in the initiation of antiviral responses. Indeed, significant differences in the
macrophages between CNV and ABX-treated mice were apparent as early as 6 hours
following infection. For rapidly replicating viruses, such a delay in initiating antiviral
pathways and activating downstream events, such as humoral and cell-mediated
adaptive immune responses, can lead to failure to control infection, as well as more
dramatic consequences such as host mortality, as was observed with influenza virus in
Chapter 2. Together, these data suggest a model in which signals from commensal
bacteria are priming the innate immune system to ensure a rapid and robust immune
response upon encounter with viral pathogens. The impact of commensal bacteriaderived signals on shaping innate immune cells prior to infection will be addressed in
Chapter 4.
This chapter established that commensal bacteria influence activation of IFN signaling,
a ubiquitous innate antiviral response pathway. Induction of a type I IFN response is
fundamental and critical for defense against the majority of viruses and is a hard-wired
response usually induced within minutes to hours of viral infection (Ramshaw et al.,
1997; Sen, 2001). Macrophages isolated from ABX-treated mice, however, displayed
defects in phosphorylation of STAT1, an immediate downstream molecule of type I IFN/
IFN receptor interactions, early following viral infection compared to macrophages from
CNV mice. This reduction in STAT1 phosphorylation was associated with a significant
decrease in proinflammatory cytokine production and reduced induction of antiviral
defense genes.
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It was notable that macrophages isolated from ABX-treated mice that had not been
infected with LCMV also displayed less detectable in vivo STAT1 phosphorylation
compared to macrophages from naïve CNV counterparts (Figure 23). This trend was
consistent over several experiments, however did not reach statistical significance.
Potentially, commensal bacteria-derived signals may induce tonic, low-level STAT1
activation at steady-state impacting basal transcription of antiviral defense genes prior to
infection. This possibility will be further explored in Chapter 4. Notwithstanding this, the
mechanisms through which commensal bacteria-derived signals stimulate immune cells
in the periphery are poorly understood. One possibility is that lymphoid tissue-resident
immune cells are directly exposed to commensal bacteria or their products. Small
numbers of live commensal bacteria can be found in the Peyer’s patches and
mesenteric lymph nodes of mice at steady-state, and there is some evidence that
absorbed commensal products circulate throughout the host (Clarke et al., 2010;
Macpherson and Uhr, 2004; Obata et al., 2010). Thus, direct interaction between
peripheral immune cells and microbial products is plausible; however, the mechanism of
microbial translocation from sites of bacterial colonization remains poorly defined.
Another possibility is that commensal bacteria act indirectly on peripheral immune cells
via responses evoked from epithelial or other mucosal-associated cells. Commensaldriven secretion of epithelial-derived cytokines can regulate intestinal immune cell
homeostasis (Bouskra et al., 2008; He et al., 2007; Rimoldi et al., 2005b; Zaph et al.,
2007), raising the possibility that epithelial cells exposed to commensal bacteria in the
steady-state could secrete immunomodulatory factors into the circulation that influence
other hematopoietic cells. Defining the potential pathways involved in microbial sensing
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by the peripheral immune system will be crucial to understanding how microbial
crosstalk influences immune cell homeostasis and host protective immunity.
In summary, these studies have uncovered a previously unrecognized role for
commensal bacteria-derived signals in influencing the immune response to a systemic
virus.

In addition, these studies provide novel insights into how distinct microbial

sensing and response pathways are integrated and provide evidence for critical crossregulation of antiviral immunity by bacterial communities. These findings could lead to
new opportunities to improve antiviral immunity and to understand the role of commensal
bacteria in influencing patients’ predisposition to distinct immunologic and pathologic
outcomes from viral infections.
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Figure 18. Systemic LCMV T1b infection results in delayed viral clearance and
reduced expansion of the LCMV-specific CD8 T cell response in ABX-treated
mice.

Figure 18. (A) Total bacterial 16S rDNA in stool samples from naïve CNV or ABX‐treated mice
following two weeks of antibiotic treatment. (B‐E) CNV or ABX‐treated C57BL/6 mice were
infected i.v. with 2x106 PFU of LCMV T1b. (B) Viral titer in the serum following infection
(L.o.D., limit of detection). LCMV‐specific (C) DbGP33 and (D) DbGP276 tetramer+ CD8 T cells
per 106 peripheral blood mononuclear cells (PBMCs) at d7, 14, and 23 post‐infection. (E)
Serial dilution of LCMV‐specific IgG antibody titers in serum of CNV or ABX‐treated mice at
d23 post‐infection. Naïve serum from CNV mice used for baseline. Data representative of
three independent experiments with n=5 mice per group. Data shown are the mean ± SEM.
Serum viral titer statistics determined by two‐part t‐test for each timepoint. *p<0.05,
**p<0.01.
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Figure 19. ABX-treated mice exhibit persisting viral reservoirs and fewer LCMVspecific CD8 T cells at D31 post-infection.

Figure 19. (A) Viral load in the kidney of CNV or ABX‐treated mice at d31 post‐LCMV
infection. (B) Total number of DbGP33, DbGP276, and DbNP396 tetramer+ CD8 T cells in the
spleen. Data representative of two‐three independent experiments with n=5 mice per group.
Data shown are the mean ± SEM. *p<0.05, **p<0.01, ***p<0.001.
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Figure 20. Increased expression of inhibitory receptors on LCMV-specific CD8 T
cells in ABX-treated mice.

Figure 20. (A) Expression of inhibitory receptors PD‐1, 2B4, CD160, LAG‐3 on DbGP33
tetramer+ CD8 T cells isolated from the spleen of CNV (black line) or ABX‐treated (red line)
mice at d31 post‐LCMV infection. Shaded histograms represent CD44lo CD8 T cells. Numbers
in italics represent mean fluorescence intensity (MFI). (B) Proportion of DbGP33 tetramer+
CD8 T cells expressing multiple inhibitory receptors. Data representative of two‐three
independent experiments with n=5 mice per group. Data shown are the mean. *p<0.05,
**p<0.01.
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Figure 21. LCMV-specific CD8 T cells isolated from ABX-treated mice produce
less effector cytokines.
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Figure 21. Splenocytes from d31 LCMV‐infected mice were incubated with GP33 peptide
(A,B) or a pool of 20 LCMV‐specific peptides (C,D) (Kotturi et al., 2007) for 5 hrs in the
presence of BFA and assessed for production of effector molecules (IFN‐γ, TNF‐α, MIP‐1α,
CD107a, IL‐2). (A) Frequency of IFN‐γ/TNF‐α dual producing CD8 T cells in the spleen
following GP33 peptide stimulation. (B) Proportion of GP33 peptide responsive CD8 T cells
producing multiple effector molecules. (C) Frequency and (D) total number of IFN‐γ/TNF‐α
dual producing CD8 T cells in the spleen following stimulation with pooled LCMV peptides.
FACS plots gated on live, CD8α+ cells. Data representative of two‐three independent
experiments with n=5 mice per group. Data shown are the mean ± SEM. *p<0.05, **p<0.01.
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Figure 22. ABX-treated mice exhibited a functionally impaired CD4 T cell response
following LCMV infection.

Figure 22. (A) Total number of I‐AbGP61 tetramer+ CD4 T cells in the spleen of CNV or ABX‐
treated mice at d31 post‐LCMV infection. (B) Expression of PD‐1 on I‐AbGP61 tetramer+ CD4
T cells from the spleen of CNV (black line) or ABX‐treated (red line) mice at d31 post‐
infection. Shaded histogram represents CD44lo CD62Lhi naïve CD4 T cells. Numbers in italics
represent MFI. (C) Splenocytes from d31 infected mice were either stained with I‐AbGP61
tetramer or incubated with LCMV peptide (GP61‐80) for 5 hrs in the presence of BFA and
assessed for production of IFN‐γ and IL‐2. Data shown are the mean ± SEM. *p<0.05.
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Figure 23. Innate antiviral immune response is diminished in ABX-treated mice
following LCMV infection.
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Figure 23. (A) Fold induction of antiviral defense genes in the spleen 12 hrs following LCMV
infection compared to expression in the spleen of naïve CNV mice. (B) IFN‐β levels in the
serum at 12 hrs post‐LCMV infection as detected by ELISA. (C) Proinflammatory cytokine
levels in spleen homogenates at 6‐24hr post LCMV infection (n.d., not detectable). (D)
Expression of MHC‐I and CD86 on peritoneal macrophages and (E) MHC‐II and CD86 on
peritoneal dendritic cells from CNV or ABX‐treated mice 24 hrs post LCMV infection. Data
representative of two or more independent experiments with n=3‐5 mice per group. Data
shown are the mean ± SEM. *p<0.05, **p<0.01.
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Figure 24 Antiviral macrophage response is impaired in ABX-treated mice
following LCMV infection.

Figure 24. CNV or ABX‐treated mice were inoculated with LCMV or PBS i.v. and (A,B)
splenocytes at 6 hrs post‐infection or (C,D) peritoneal exudate cells at 12 hrs post‐infection
were isolated and immediately fixed to preserve the in vivo STAT1 phosphorylation status of
macrophages. (A,B) Frequency of pSTAT1+ splenic macrophages. Splenic macrophages gated
on Non T, Non‐B, Non NK cells (NTNBNNK), CD11c‐, Ly6g‐, Ly6c‐, F4/80+, CD11blo. (C,D)
Frequency of pSTAT1+ peritoneal macrophages. Peritoneal macrophages gated on NTNBNNK,
F4/80+, CD11b+. Data representative of two independent experiments with n=3‐5 mice per
group. Data shown are the mean ± SEM. *p<0.05, **p<0.01.
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Chapter 4
Commensal bacteria-derived signals calibrate the activation
threshold of the innate immune system
4.1 Abstract
Commensal bacterial communities shape intestinal immune cell homeostasis and can
influence the predisposition to intestinal and systemic inflammatory and autoimmune
diseases. Further, commensal bacteria can act as an adjuvant and boost the immune
response to an ongoing infection. However, it is unclear whether commensal bacteriaderived signals can shape immune cell activation prior to infection rendering the immune
system more or less susceptible to a potential pathogenic challenge. Defective
macrophage responses to viral infection in mice depleted of commensal bacterial
communities, as reported in Chapters 2 and 3, suggested an inherent impairment in the
ability of macrophages from ABX-treated mice to respond to viruses. Genome-wide
transcriptional profiling of macrophages isolated from naïve ABX-treated mice revealed
decreased expression of genes associated with antiviral immunity. Moreover,
macrophages isolated from ABX-treated mice exhibited defective responses to type I/II
IFNs and impaired capacity to limit viral replication. Transfer of macrophages from CNV
mice into ABX-treated mice immediately prior to LCMV infection improved the virusspecific adaptive immune response and restored the ability to control viremia.
Collectively, these data indicate that commensal bacteria-derived signals provide tonic
immune stimulation that calibrates the activation threshold of the innate immune system
required for optimal antiviral immunity.
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4.2 Introduction
Host defense against invasive pathogens requires a coordinated response by the innate
and adaptive immune system. The role of the innate immune system is detection of
pathogens and initiation of the proper immune response needed to eliminate infection. In
the absence of antigen-specificity, which evolved with the adaptive immune system to
enable a targeted immune response against a specific pathogen, the innate immune
system relies on germ-line encoded PRRs that recognize distinct PAMPs to distinguish
between types of pathogens. PAMP recognition by PRRs expressed by innate immune
cells activates defense pathways that initiate immune responses tailored to effectively
combat the particular class of pathogen from which the PAMP originates (Medzhitov,
2007). For example, the innate immune response to parasitic infection leads to activation
of genes programmed to prevent colonization and expel the parasite (Reese et al., 2007;
Stetson et al., 2004) while viral infection activates genes that limit cytosolic RNA
synthesis and thus viral replication (Seth et al., 2006). These innate defense
mechanisms can be constitutively expressed, thereby limiting the ability of pathogens to
establish a productive infection, but must also be carefully balanced, as overexpression
of host defense genes can be detrimental to the host. For example, constitutive
expression of type I IFN, a potent antiviral cytokine, can lead to autoimmune diseases
when unchecked by negative regulators (Arakura et al., 2007; Hida et al., 2000). In
addition, overexpression of proinflammatory cytokines in the intestine, which have
important roles in maintaining the intestinal barrier, are associated with an increased
incidence of IBD and colonic cancer (Karin et al., 2006; Papadakis and Targan, 2000).
Thus, the innate immune system must be dynamically calibrated to enable rapid
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response upon encounter with pathogens while limiting detrimental side effects to the
host.
The mammalian innate immune system has evolved diverse strategies to detect and
respond to a vast array of microbial signals, allowing induction of distinct defense
mechanisms tailored to different types of pathogens (anti-bacterial vs. antiviral vs. antiprotozoan response) (Medzhitov, 2007). Despite this apparent specialization in pattern
recognition and induction of innate immune responses, crosstalk between pathways has
been reported where stimulation from one class of pathogens influences the immune
response against another class (Actor et al., 1993; Barton et al., 2007; Spencer et al.,
1977). However, it is unclear if commensal bacteria influence innate immune pathways
in the steady-state and, if so, whether these interactions modulate the systemic immune
response to viral pathogens. Iwasaki and colleagues reported impaired antiviral
immunity in the lung following deliberate manipulation of commensal bacteria (Ichinohe
et al., 2011). This effect was associated with defective activation of the inflammasome,
a pathway activated by bacterial products that is also important in conferring protective
immunity against a subset of viruses, including influenza virus and poxviruses (Lamkanfi
and Dixit, 2011). Whether depletion of commensal bacteria selectively regulates
inflammasome-dependent pathways or represents broader immunological crosstalk
between commensal bacteria and other antiviral pathways remains to be determined.
In this chapter, I examine this fundamental question and demonstrate a critical role for
commensal bacteria in setting the immune activation threshold of macrophages required
for antiviral immunity. Manipulating commensal bacterial communities dramatically
impaired host protective immunity following either mucosal (influenza virus, Chapter 2)
or systemic (LCMV, Chapter 3) viral infection, leading to dysregulated adaptive immune
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responses and underlying defects in innate antiviral defense pathways. Genome-wide
transcriptional profiling of macrophages isolated from naive ABX-treated mice revealed
reduced expression of genes associated with IFN activation and antiviral immunity
indicating an inherent impairment in responsivness to viruses in ABX-treated mice prior
to infection. Moreover, transfer of macrophages isolated from CNV mice into ABXtreated mice re-established antiviral immunity to LCMV infection in ABX-treated mice.
Taken together, these data indicate that commensal bacteria provide tonic signals that
calibrate the activation threshold and sensitivity of the innate antiviral immune system.

4.3 Methods
4.3.1 Mice
C57BL/6 mice (4-6 weeks old) were purchased from the National Cancer Institute
(Frederick, MD). Mice were maintained in specific pathogen–free facilities at the
University of Pennsylvania. GF Swiss/Webster mice were maintained in plastic isolator
units and fed autoclaved chow and water. The University of Pennsylvania Institutional
Animal Care and Use Committee (IACUC) approved all protocols, and all experiments
were performed according to the guidelines of the University of Pennsylvania IACUC.
4.3.2 Oral antibiotic treatment
Mice were provided autoclaved drinking water supplemented with ampicillin (0.5 mg/mL,
Sigma), gentamicin (0.5 mg/mL, Gemini Bio-Products), metronidazole (0.5 mg/mL
Sigma), neomycin (0.5 mg/mL, Med-Pharmex), vancomycin (0.25 mg/mL, Novaplus),
and sucralose (4mg/mL, Splenda, McNeil Nutritionals, LLC). Splenda was added to
make the antibiotic cocktail more palatable. Antibiotic treatment was started 2-4 weeks
prior to infection and continued for the duration of the experiment.
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4.3.3 Isolation of cells and flow cytometric staining
Single cell suspensions were isolated from the spleen by mechanical disruption through
70µm cell strainers followed by red blood cell (RBC) lysis. Peritoneal exudates cells
(PECs) were obtained by injecting and recovering PBS from the peritoneal cavity. Cells
were surface stained in FACS Buffer (PBS, 2% BSA, 0.2mg Sodium Azide, 2mM EDTA)
using standard flow cytometric staining protocol with fluorescently conjugated antibodies
specific to CD3ε, CD4, CD8α, CD11c, CD19, CD25, CD43, CD45, CD69, CD119,
CD160, F4/80, Ly6c, MHC-I (H-2Kb), MHC-II (I-A/I-E) (eBioscience), CD5, CD44, CD80,
CD86, Ly6g (clone 1A8), ICOS, LAG-3, PD-1 (clone RMP1-30) (Biolegend), CD40,
IFNαRI (BD Biosciences), CD11b (Invitrogen).

4.3.4 Cell sorting and microarray-data analysis
Peritoneal macrophages (CD3ε-, CD19-, CD11b+, F4/80+) from naïve CNV or ABXtreated mice were sorted directly into TRIzol LS (Invitrogen) on a BD Aria (Beckson
Dickson). Additional macrophages from the sample were separately sorted to ensure
sort purity (≥95%). For microarray analysis, RNA was extracted from sorted peritoneal
macrophages from three biological replicates of naïve CNV or ABX-treated mice. cDNA
was amplified using NuGen WT Ovation Pico kit and hybridized to Affymetrix GeneChip
Mouse Gene 1.0 ST microarray at the University of Pennsylvania's Microarray facility.
Expression levels were summarized using the Robust Multichip Averaging (RMA)
algorithm (Irizarry et al., 2003), as implemented by the Affymetrix Power Tool (aptprobeset-summarize). The ClassNeighbors module of GenePattern (Broad Institute,
Cambridge MA) was used to identify differentially expressed genes. Gene transcripts
with greater than 1.6-fold difference in expression were analyzed using Ingenuity
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pathway analysis software (Ingenuity® Systems, www.ingenuity.com). A right-tailed
Fisher’s exact test was used to calculate a p-value determining the probability that the
association between the genes in the dataset and the pathway or biological function
could be explained by chance. GSEA was performed as described (Subramanian et al.,
2005).
4.3.5 IFN stimulation and Phosflow STAT1 staining of macrophages
PECs from naïve CNV or ABX-treated mice were plated on a 6 well plate for 3 hrs to
allow macrophage adherence. Non-adherent cells were washed away with PBS and
remaining cells were counted and seeded at 1x105 cells per well in complete media in a
96 well plate and incubated at 37oC for 3 hrs to allow cell adherence. Media was then
removed and cells washed 2x with PBS. Macrophages were stimulated with recombinant
IFN-γ (R&D Systems) or IFN-β (PBL Interferonsource) in complete media. Following
stimulation, media was removed and replaced with 0.05% trypsin and incubated at 37oC
for 2 minutes. Cells were then fixed with 1.6% PFA in complete media for ten minutes at
room temperature, transferred to a 96-well round bottom plate, centrifuged, and
permeabilized with ice cold 90% methanol for 10 minutes. Cells were washed 3x with
FACS buffer and stained for surface markers and with PE-conjugated anti-STAT1
(pY701) antibody (BD biosciences) as described in (Krutzik and Nolan, 2003).
4.3.6 In vitro viral infection of peritoneal macrophages
Sort-purified macrophages isolated from naïve CNV or ABX-treated mice were seeded
at 1x105 cells per well in a 96-well plate and incubated at 37oC for 3 hrs to allow cell
adherence. Macrophages were then infected with either LCMV clone 13 strain (MOI of
0.2) or influenza virus X31-GP33 strain (MOI of 5) for 1 hr then washed 2x to remove
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virus. At indicated timepoints, supernatants were collected to assess viral titers by
plaque assay or macrophages were directly lysed using RLT lysis buffer (Qiagen) and
RNA was isolated using an RNeasy mini-kit (Qiagen). cDNA was generated using
SuperScript reverse transcriptase (Invitrogen). RT-PCR was performed on cDNA using
SYBR green chemistry (Applied Biosystems) and commercially available primer sets
(Qiagen).
4.3.7 Macrophage purification and transfer
PECs from CNV or ABX-treated mice were isolated on day -1, 0, 1 of LCMV (T1b strain)
infection. PECs were incubated with biotin CD3ε, CD5, CD11c, CD19, B220, and Ter119 for 15 min at 4 °C followed by incubation with strepavidin conjugated magnetic
beads (Dynabeads) for 20 min at 4 °C. Samples were separated by magnet and the
negatively selected cells were collected. An aliquot was set aside to determine
macrophage (CD11b+, F4/80+) purity (~60-80%). 3x105 macrophages were transferred
retro-orbitally into day of infection matched ABX-treated recipient mice.

4.3.8 Statistical analysis
Results represent means ± SEM. Statistical significance was determined by the
unpaired, two tailed, Student’s t-test for individual timepoints, two-way ANOVA test for
timecourse experiments, logrank test for survival curve, or two-part t-test for comparison
of groups that contained samples that were below the limit of assay detection. Statistical
analyses were performed using Prism GraphPad software v4.0. (*p < 0.05; **p < 0.01;
***p < 0.001).
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4.4 Results
4.4.1 Macrophages, but not dendritic cells, exhibit an altered activation profile
prior to viral infection in ABX-treated mice
Chapters 2 and 3 demonstrated an integral role for commensal bacterial communities in
shaping the innate and adaptive immune response to mucosal or systemic viral infection.
This chapter will investigate the mechanisms through which commensal bacteria-derived
signals modulate antiviral immunity. Early defects in the innate antiviral immune
response following influenza virus or LCMV infection in ABX-treated mice provoke the
hypothesis that commensal bacteria-derived signals regulate the basal activation status
of innate immune cells prior to viral infection. Therefore, to interrogate the potential
mechanisms through which signals derived from commensal bacteria regulate innate
immune

responses

and

antiviral

immunity,

a

phenotypic

characterization

of

macrophages and dendritic cells isolated from the peritoneal cavity of naïve CNV or
ABX-treated mice was performed. Macrophages (Figure 25A), but not dendritic cells
(Figure 25B), isolated from ABX-treated mice selectively displayed decreased
expression of a class of molecules (MHC-I, IFNγRI, CD40 and CD86) that are critical for
the early propagation of the immune response to viral infection. These observations
provide evidence that in the steady-state commensal bacteria-derived signals can shape
immune cell activation status outside of the intestinal tract and contribute to maintaining
macrophages in a poised state capable of rapidly respond to an invading pathogen.

106

4.4.2 Defective expression of antiviral defense genes in macrophages isolated
from ABX-treated mice prior to viral infection
Differential expression of activation molecules on macrophages isolated from naive
ABX-treated mice suggested an inherent impairment in the ability of macrophages to
respond to infection. To interrogate the potential mechanisms through which signals
derived from commensal bacteria regulate macrophage responses and innate antiviral
immunity, we employed genome-wide transcriptional profiling of macrophages isolated
from ABX-treated or CNV mice prior to viral infection. Fundamental differences in
transcriptional profiles were readily apparent between macrophages isolated from CNV
versus ABX-treated mice (Figure 26A). To further define these transcriptional
differences, two separate analyses were conducted. First, Ingenuity Pathways Analysis
(IPA) was used to identify enriched biological processes and networks. In total, there
were 367 gene transcripts upregulated by at least 1.6 fold in macrophages isolated from
CNV mice relative to macrophages isolated from ABX-treated mice (Figure 26B).
Analysis of the 367 gene transcripts using IPA identified the IFN signaling pathway as
the most significantly enriched pathway in macrophages isolated from CNV mice versus
ABX-treated mice (Figure 26C). IPA can also identify complex biological networks by
cross-referencing gene lists with a database consisting of empirically defined biological
interactions between different genes. This analysis enables visualization of how different
molecules interact to form complex biological networks. IPA identified the STAT1/STAT2
transcription factor complex as one of the central molecules in the network of
inflammatory immune response genes elevated in macrophages isolated from CNV mice
compare to ABX-treated mice (Figure 27A) Further analysis of this complex immune
network revealed that macrophages isolated from ABX-treated mice had defects in
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immune response genes critical in detecting viral infection and limiting viral replication
(Figure 27B). Thus IPA suggested an inherent defect in the antiviral immune response
following antibiotic-mediated disruption of commensal bacterial communities.
In addition to IPA, a second approach using gene set enrichment analysis (GSEA) was
undertaken to compare the gene transcription profile of macrophages isolated from CNV
mice to macrophages isolated from ABX-treated mice. GSEA enables an unbiased
analysis of the whole genome microarray data to identify coordinated patterns of gene
expression based on empirically defined gene sets (Haining and Wherry, 2010;
Subramanian et al., 2005). GSEA revealed that six of the top eight most enriched gene
sets in macrophages from CNV mice were related to IFN responses (Figure 28A,B). In
addition, macrophages isolated from CNV mice were relatively enriched in a set of
genes, independently reported by Agarwal et al. (Agarwal et al., 2009), responsive to
IFN-α stimulation (Figure 28C). Specific gene expression analysis of macrophages
isolated from ABX-treated mice revealed a relative downregulation of several genes that
regulate detection of virus (Ifih1 (MDA5), Ddx58 (RIG-I)), the response to interferon
signaling (Irf7, Ifngr1, Stat1, Stat2) or inhibition of viral replication (Mx1, Oas1a) (Figure
29A), but not genes associated with the inflammasome (Figure 29B) or TLR signaling
pathways (Figure 29C), two alternative innate pathogen recognition mechanisms.
Differential

expression

of

IFN-pathway

related

antiviral

defense

genes

was

independently confirmed by qRT-PCR analysis on sorted macrophages from naïve CNV
or ABX-treated mice (Figure 29D). Taken together, genome-wide transcriptional profiling
and computational analyses suggest that signals derived from commensal bacteria
calibrate the activation threshold of antiviral immune response pathways in
macrophages.
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4.4.3 Alteration or absence of commensal bacteria renders macrophages less
responsive to IFN stimulation or viral infection
Genome-wide transcriptional profiling suggested that commensal bacteria-derived
signals modulate the responsiveness of macrophages to viral infection or IFN
stimulation. To functionally test this hypothesis, the response of macrophages isolated
from naive CNV or ABX-treated mice to IFN stimulation or viral infection was assessed
ex vivo. IFN receptor signaling by type I or II IFNs results in phosphorylation of STAT1
followed by translocation into the nucleus, where pSTAT1 initiates transcription of an
array of IRGs crucial to the early antiviral response (Schindler et al., 1992; Shuai et al.,
1992). To test IFN responsiveness, macrophages isolated from naïve, CNV or ABXtreated mice were stimulated with IFN-γ (0.4-200ng/mL) or IFN-β (1x103U/mL) for 5-15
minutes in vitro, and phosphorylation of STAT1 was measured by flow cytometry.
Stimulated macrophages isolated from ABX-treated mice exhibited significantly reduced
pSTAT1 levels compared to CNV macrophages following IFN-γ (Figure 30A,B) or IFN-β
(Figure 30C,D) stimulation. Similar deficiencies in STAT1 phosphorylation were
observed following IFN-γ (Figure 31A,B) or IFN-β (Figure 31C,D) stimulation of
macrophages isolated from GF mice. These biological observations are consistent with
diminished expression of antiviral defense genes identified by transcriptional profiling
(Figure 26-29), and, together, suggest that signals from commensal bacteria are crucial
to maintain optimal responsiveness to IFN stimulation in macrophages.
To examine whether these deficiencies impaired macrophage responsiveness to viral
infection, macrophages isolated from CNV or ABX-treated mice were infected ex vivo
with influenza virus (X31-gp33) and induction of antiviral defense genes was examined.
This method of direct ex vivo viral infection of isolated macrophages assesses whether
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macrophages are intrinsically impaired in responding to viruses. Expression of multiple
antiviral defense genes (Mx1, Oas1a, Ifnb, Stat2), identified from our microarray analysis
(Figure 29A,D), was reduced in macrophages from ABX-treated mice compared to CNV
mice at 6-24 hrs after infection, indicating an impaired ability to respond to viral infection
(Figure 32). Further, macrophages isolated from ABX-treated (Figure 33A) or GF (Figure
33B) mice supported significantly more viral replication upon ex vivo infection with LCMV
demonstrated by higher titers of virus present in the supernatant at 48-72 hrs postinfection compared to CNV macrophages. Combined, these data demonstrate that
manipulation of commensal bacterial communities by ABX treatment fundamentally
alters expression of antiviral defense genes, rendering cells of the innate immune
system less able to respond to viral infection.
4.4.4 Adoptive transfer of macrophages isolated from CNV mice improves control
of viral replication and quality of antiviral immune response in ABX-treated mice
Tonic signaling from commensal bacteria primes macrophages to rapidly respond to
virus and virus-induced interferon stimulation (Figure 29-32). Further, in Chapter 2 and 3
we reported that ABX-mediated disruption of commensal bacterial communities renders
mice susceptible to viral infection. To assess if commensal bacteria-derived tonic
signaling on macrophages is sufficient restore antiviral immune responses and control
viral replication in ABX-treated mice, macrophages from CNV mice were adoptively
transferred into ABX-treated mice at d -1,0, and 1 following LCMV infection (Figure 34A).
As an additional control, macrophages from ABX-treated mice were adoptively
transferred to another group of ABX-treated mice. Thus, upon LCMV infection ABXtreated recipient mice received either commensal bacteria “exposed” or “unexposed”
donor macrophages. Following LCMV infection, the immune response and control of
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viral replication in macrophage recipient ABX-treated mice was compared to CNV mice
and ABX-treated mice that did not receive macrophage transfers.
Following macrophage transfer and LCMV infection, the four groups (CNV, ABX, ABX
+ CNV Macs, ABX + ABX Macs) were longitudinally assessed for serum viral titers and
LCMV-specific CD8 T cell responses. Consistent with experiments reported in Chapter
3 (Figure 18), CNV mice cleared virus from the serum within 2 weeks following infection
while ABX-treated mice exhibited persisting viremia for a month (Figure 34B). In
contrast, ABX-treated mice receiving “commensal exposed” macrophages exhibited
significantly improved control of virus in the serum compared to ABX-treated mice
(Figure 34B). ABX-treated mice, receiving “commensal unexposed” macrophages,
however, exhibited persisting viremia for a month following infection (Figure 34B). Thus,
only donor macrophages harvested from an environment where commensal bacteriaderived signals were present were able to improve viral control in ABX-treated mice.
Fewer LCMV-specific H-2Db gp33 (Figure 34C) and H2-Db gp276 CD8 tetramer+
(Figure 34D) T cells were detected within the peripheral mononuclear cells (PBMC)
isolated from the blood of ABX-treated mice at d23 post-infection. Phenotypic
characterization of LCMV-specific CD8 T cells isolated from ABX-treated mice revealed
increased expression of the inhibitory receptor PD-1 (Figure 34E,F), which has been
shown to be associated with the quality of the antiviral immune response (Barber et al.,
2006; Blackburn et al., 2009), indicating ABX-treated mice had an impaired antiviral
immune response that correlated with delayed viral clearance, consistent with the results
reported in Chapter 3. However, ABX-treated mice receiving “commensal exposed”
macrophages,

but

not

ABX-treated

mice

receiving

“commensal

unexposed”

macrophages, exhibited significantly increased populations of LCMV-specific CD8 T
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cells in the blood at d23 post-infection (Figure 34C,D) compared to ABX-treated mice not
receiving a macrophage transfer. The LCMV-specific CD8 T cells from ABX + CNV Macs
mice also expressed less PD-1 (Figure 34E,F) suggesting the macrophage transfer also
improved the quality of the antiviral immune response.
At d31 post-infection the four groups of mice were sacrificed and splenocytes were
stimulated with a pool of 20 LCMV-specific peptides (Kotturi et al., 2007) and assessed
for effector cytokine production to interrogate the functional quality of the LCMV-specific
CD8 T cell response. Consistent with previous observations (Chapter 3, Figure 21),
ABX-treated mice exhibited significantly decreased frequency (Figure 35A) and total
numbers (Figures 35B) of IFN-γ+/TNF-α+ dual producing splenic CD8 T cells compared
to CNV mice. In contrast, ABX-treated mice receiving “commensal exposed”
macrophages,

but

not

ABX-treated

mice

receiving

“commensal

unexposed”

macrophages, exhibited a significant increase in the frequency and total number of IFNγ+/TNF-α+ dual producing CD8 T cells compared to ABX-treated mice (Figure 35A,B),
indicating a significant improvement in the quality of the adaptive antiviral immune
response. Thus, macrophages previously exposed to commensal bacteria-derived
signals were sufficient to partially restore control of viral replication and improve the
antiviral immune response in an environment devoid of commensal bacteria-derived
signals. Collectively, these data demonstrate the in vivo relevance of tonic signaling by
commensal bacteria in setting the immune activation threshold of macrophages required
for antiviral immunity.
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4.5 Discussion
The results described in this chapter reveal a novel interplay between commensal
bacteria and antiviral IFN signaling pathways that is critical in response to viral infection.
Genome-wide transcriptional profiling uncovered a global defect in expression of antiviral
defense genes in macrophages isolated from ABX-treated mice compared to
macrophages from CNV mice prior to viral infection. This reduction in steady-state
transcription of antiviral defense genes was associated with a significant deficiency in
responsiveness to virus or the virus-induced type I/II IFNs. Furthermore, adoptive
transfer of macrophages isolated from CNV mice, but not ABX-treated mice, was
sufficient to restore antiviral immunity in ABX-treated mice.

Collectively, these data

indicate a previously unrecognized aspect of innate immune cross-talk where low-level
tonic signaling by commensal bacteria calibrate the activation threshold of innate
antiviral immune responses.
Tonic signaling has been proposed to be a mechanism to maintain optimal
responsiveness of signaling pathways in other settings (Macia et al., 2009). For
example, naïve T cells use low affinity interactions with self MHC to generate tonic
signals thought to be important for naïve T cell homeostasis and for optimal dynamic
responsiveness upon engagement of cognate antigen (Takeda et al., 1996; Tanchot et
al., 1997). Similarly, pre-TCR and pre-BCR are used during lymphocyte development to
generate low-level signals that help guide these cells to maturity (Rajewsky, 1996; Scott
et al., 1989). The tonic signaling involved in maintaining responsiveness of antiviral
pathways described in this chapter was not dependent on signals that normally evoke
antiviral IFN responses but rather on commensal bacteria-derived signals. Such
crosstalk between anti-bacterial and antiviral immunity can occur in other settings. For
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example, latent viral infections can render mice less susceptible to bacterial challenge,
an effect attributed to basal macrophage activation driven by antiviral IFN-g production
(Barton et al., 2007). Conversely, the symbiotic bacteria, Wolbachia, confers protection
against viral infections in Drosphilia (Teixeira et al., 2008). Anti-bacterial responses
driven by LPS triggered TLR4 signaling can also upregulate transcription of antiviral
genes (Amit et al., 2009; Doyle et al., 2002). In the case of LPS/TLR4 signaling, antiviral
gene expression is initially induced, but rapidly limited by the polycomb repressor Cbx4
(Amit et al., 2009).
This latter observation suggests a potential explanation for the commensal-antiviral
immune fitness axis at the transcriptional level. Induction of transcription followed by
repression might maintain key antiviral genes in a state of poised transcriptional
regulation, rather than a repressed or inactive state.

Transcriptional poising, or the

presence of both activating and repressive chromatin, can allow for faster or more
efficient transcriptional induction upon exposure to a true inducer of the gene of interest
(Cuddapah et al., 2010; Zediak et al., 2011). This state of dynamic transcriptional
regulation provided by tonic commensal bacteria stimulation may enable rapid induction
of antiviral defense genes upon infection. Examples of this type of regulation exist in
other settings. In yeast, the Hog1/MAPK pathway uses basal signaling and a negative
feedback loop to maintain rapid and sensitive responses to environmental stimuli,
suggesting that a pathway with active low-grade signaling might be biologically more
responsive than one that lies dormant until a de novo signal is received (Macia et al.,
2009). Our results suggest commensal bacteria provide such a signal that maintains
antiviral innate immune pathways in a state of optimal readiness allowing dynamic and
robust responses upon challenge by systemic or mucosal viral infections.
114

Figure 25. Macrophages isolated from ABX-treated mice exhibit reduced
expression of activation molecules in the steady-state.
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Figure 25. Phenotypic characterization of (A) macrophages or (B) dendritic cells isolated from
the peritoneal cavity of naïve CNV (black line) or ABX‐treated (red line) mice. Shaded
histogram represents isotype control (or FMO for MHC‐I and TLR‐9). FACS plots gated on live,
CD45+, non‐T, non‐ B, non‐NK cells. Data representative of three independent experiments.
n=4‐5 mice per group. Data shown are the mean ± SEM. *p<0.05, **p<0.01, ***p<0.001.
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Figure 26. Macrophages isolated from ABX-treated mice have an altered gene
expression profile.
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Figure 26. RNA was extracted from sort‐purified peritoneal macrophages (sorted on CD3ε‐,
CD19‐, F4/80+, CD11b+) isolated from naïve CNV or ABX‐treated mice. Extracted RNA was
hybridized to an Affymetrix GeneChip microarray to assess gene expression. (A) Heat map of
differentially expressed genes in macrophages isolated from CNV or ABX‐treated mice. Red =
high expression, blue = low expression. (B) Frequency and total number of elevated gene
transcripts in CNV macrophages compared to macrophages isolated from ABX‐treated mice.
(C) Highly enriched biological pathways and functions found within the subset of elevated
gene transcripts from CNV macrophages as assessed by Ingenunity Pathways Analysis. Red
bars indicate the percent of genes in a pathway upregulated in macrophages isolated from
CNV mice. Yellow line indicates p‐value calculated by Fisher’s Exact test.
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Figure 27. Key molecules in the inflammatory immune response network are
relatively elevated in macrophages isolated from CNV mice.
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Figure 27. (A) Ingenuity Pathway analysis identified direct and indirect biological interactions
amongst the subset of 367 genes relatively elevated in CNV macrophages creating an
inflammatory immune response network.

Connection lines in yellow highlight the

interrelationship of STAT1 with other genes in the network. Molecules shaded in red
represent gene expressed at relatively higher levels in CNV macrophages compared to
macrophages isolated from ABX‐treated mice. (B) Simplified network identifying molecules
relatively elevated in CNV macrophages that are crucial in the detection and inhibition of
viral replication. Network maps were created using Ingenuity pathway analysis software
(Ingenuity® Systems, www.ingenuity.com)
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Figure 28. Macrophages isolated from CNV mice exhibit a relative enrichment in
IFN responsive genes.
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Figure 28. (A) Gene set enrichment analysis (GSEA) of CNV macrophages compared to
macrophages isolated from ABX‐treated mice. The most highly enriched gene sets
determined by the normalized enrichment score (NES). (B) Enrichment curve of the top
ranked gene set as defined by GSEA. (C) GSEA enrichment curve of genes upregulated
following IFN‐α stimulation, empirically defined from (Agarwal et al., 2009).
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Figure 29. (A‐C) Heat map of genes encoding (A) antiviral defense mechanisms, (B)
inflammasome components or (C) TLR signaling components in macrophages isolated from
naïve CNV or ABX‐treated mice. (D) Expression of antiviral defense genes by qPCR analysis of
RNA isolated from sort‐purified macrophages from two independent experiments with n=3‐5
mice per group. *p<0.05, **p<0.01.
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Figure 30. Macrophages isolated from ABX-treated mice have an impaired
response to type I/II IFN stimulation.

Figure 30. (A‐D) Peritoneal macrophages isolated from CNV or ABX‐treated mice were
stimulated with IFN‐γ or IFN‐β in vitro. Histograms of STAT1 phosphorylation in macrophages
following (A) IFN‐γ stimulation (0.4, 4, 20, 200ng/mL) or (C) IFN‐β stimulation (103 Units/mL
for 5, 10, and 15 minutes). Mean fluorescence intensity (MFI) of pSTAT1 in macrophages
following (B) IFN‐γ or (D) IFN‐β stimulation. Data representative of two or more independent
experiments with n=3‐5 mice per group. Data shown are the mean ± SEM. *p <0.05, ***p
<0.001.
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Figure 31. Macrophages isolated from GF mice also display an impaired response
to type I/II IFN stimulation.

Figure 31. (A‐D) Peritoneal macrophages isolated from naïve CNV or GF Swiss/Webster mice
were stimulated with IFN‐γ or IFN‐β in vitro. Histograms of STAT1 phosphorylation in
macrophages following (A) IFN‐γ (0.2, 2, 20, 200ng/mL) or (C) IFN‐β (101, 102, 103, 104
Units/mL) stimulation for 15 minutes. Mean florescence intensity (MFI) of pSTAT1 in
macrophages following (B) IFN‐γ or (D) IFN‐β stimulation. Data representative of two
independent experiments with n=3‐5 mice per group. Data shown are the mean ± SEM. ***p
<0.001.
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Figure 32. Macrophages isolated from ABX-treated mice exhibit delayed induction
of antiviral defense genes.

Figure 32. Peritoneal macrophages sorted from naive CNV or ABX‐treated mice were infected
with influenza virus in vitro (X31‐GP33, MOI of 5). RNA was purified at 6 and 24 hrs post‐
infection and analyzed by qPCR for upregulation of antiviral genes. Data representative of
three independent experiments with n=3‐5 mice per group. Data shown are the mean ± SEM.
**p<0.01.

125

Figure 33. Macrophages isolated from naive ABX-treated or GF mice have a
diminished ability to respond to viral infection in vitro.

Figure 33. Peritoneal macrophages isolated from (A) naïve C57BL/6 CNV or ABX‐treated mice
or (B) naïve CNV or GF Swiss/Webster mice were infected with LCMV cl‐13 strain (MOI of 0.2)
in vitro. LCMV viral titers in supernatant of in vitro infected macrophages at 24‐96 hrs post‐
infection were assessed by viral plaque assays. Data representative of three independent
experiments; n=3‐5 mice per group. Data shown are the mean ± SEM. *p<0.05, **p<0.01.
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Figure 34. Macrophages transferred from CNV mice into ABX-treated mice
improve viral control following LCMV infection.
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Figure 34. (A) Diagram schematic of macrophage transfer from CNV or ABX‐treated donor
mice into ABX‐treated recipients. CNV, ABX‐treated, ABX‐treated + CNV Macs, ABX‐treated +
ABX Macs mice were infected i.v. with 2x106 PFU of LCMV T1b. (B) Viral titer in the serum
following infection (L.o.D., limit of detection). LCMV‐specific (C) DbGP33 and (D) DbGP276
tetramer+ CD8 T cells per 106 peripheral blood mononuclear cells (PBMCs) at d23 post‐
infection. (E‐F) Expression of inhibitory receptor PD‐1 on (E) DbGP33 or (F) DbGP276
tetramer+ CD8 T cells isolated from the blood at d23 post‐infection. Viral titer statistics
determined by two‐way ANOVA comparing CNV to ABX (p<0.01), ABX + CNV Macs to ABX
(p<0.01), or ABX + ABX Macs (n.s.). Data shown are the mean ± SEM. *p<0.05, **p<0.01.
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Figure 35. Adoptive transfer of CNV macrophages improves quality of LCMVspecific CD8 response in ABX-treated mice.
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Figure 35. (A) Splenocytes from d31 infected mice were incubated with a pool of 20 LCMV‐
specific peptides (Kotturi et al., 2007) for 5 hrs in the presence of BFA and CD8 T cells were
assessed for production of IFN‐γ and TNF‐α. FACS plots gated on live, CD8α+ cells. (B) Total
number of IFN‐γ/TNF‐α dual producing CD8 T cells in the spleen at d31 post‐infection. Data
shown are the mean ± SEM. *p<0.05, **p<0.01.
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Chapter 5
Summary, Discussion and Future Directions
5.1 Commensal bacterial communities modulate immune responses to
infection
The innate immune system has evolved to detect distinct molecular patterns conserved
within specific groups of pathogens. This enables the innate immune system to be able
to respond to a multitude of pathogens with a relatively limited number of pathogen
recognition mechanisms. For example, TLR4 detects lipopolysaccarides (LPS) that are
prominently displayed on the outer membrane of all gram-negative bacteria (Miller et al.,
2005), while cytosolic proteins such as RIG-I and MDA5 can detect cytoplasmic dsRNA,
a common intermediate in the replication cycle of viruses (Medzhitov, 2007). Detection
of PAMPs initiates a cascade of signaling pathways that results in induction of innate
immune response genes and activation of the adaptive immune system.
Intestinal commensal bacteria express the same molecular motifs as pathogenic
bacteria, yet the immune system has evolved to interact with commensal bacterial
communities without causing overt, persistent inflammation. This is accomplished, in
part, by physical separation of intestinal commensal bacteria from the intestinal epithelial
lining. Specialized IECs, called goblet cells, secrete mucin glycoproteins into the
intestinal lumen creating a mucus layer coating the intestinal epithelia and limiting
bacterial attachment to epithelial cells (Deplancke and Gaskins, 2001). Antimicrobial
peptides and commensal bacteria-specific IgA are secreted into the mucus layer further
preventing bacterial penetrance. (Macpherson et al., 2001; Vaishnava et al., 2011).
Physical separation of commensal bacteria from host cells is not absolute, however, and
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intestinal immune cells regularly come in direct contact with live commensal bacteria
(Ivanov et al., 2009; Macpherson and Uhr, 2004; Obata et al., 2010). These interactions
occur continuously throughout the life of the host and result in a dynamic relationship
between commensal bacteria and the host immune system. Intestinal immune cell
populations shaped by these interactions, can be driven to a proinflammatory or
immunoregulatory differentiated state. This homeostatic regulation of the immune
system by commensal bacterial communities can shape host fitness rendering the host
more or less susceptible to inflammation, infection, allergy, or autoimmunity (Honda and
Littman, 2012).
The data presented in this thesis describe a fundamental role for commensal bacterial
communities in setting the activation threshold the innate immune system requires to
respond to mucosal-associated or systemic viral infections. ABX-mediated disruption of
commensal bacterial communities resulted in diminished expression of antiviral defense
genes in macrophages isolated from ABX-treated mice compared to macrophages
isolated from CNV mice prior to viral infection. This observation suggests that tonic
stimulation by commensal bacteria-derived signals induces basal transcription of
antiviral defense genes in innate immune cells in the steady-state that enables rapid
immune responses upon exposure to viruses. Induction of innate immune response
genes trigger robust expansion of adaptive immune responses, and, ultimately,
successful control of infection. Even a slight delay in innate immune activation can swing
the host versus virus equilibrium in favor of the pathogen and can have severe
physiological consequences for the host. This was demonstrated in Chapter 2, in which
influenza virus infection of ABX-treated mice resulted in impaired induction of innate
proinflammatory cytokines and chemokines leading to diminished induction of adaptive
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immune responses. Impaired immune responses to influenza virus in ABX-treated mice
compared to CNV mice resulted in ineffective viral clearance, severe damage to the
bronchiole epithelium, defective gas exchange, and ultimately host mortality.
The results presented in Chapter 3 demonstrate defective antiviral innate and
adaptive immune responses to a systemic viral infection (LCMV) following ABXmediated disruption of commensal bacterial communities. Antiviral immunity could be
rescued in mice depleted of commensal bacteria by either restoring IFN responsiveness
as described in Chapter 2 or supplementing ABX-treated mice with macrophages
harvested from CNV mice and therefore exposed to commensal bacteria-derived
signals, as reported in Chapter 4. Collectively, these data indicate that in the steadystate, commensal bacteria provide tonic signals that regulate the activation threshold of
the innate immune system required for optimal antiviral immune responses (Figure 36).

5.2 Dynamic interrelationship between the immune system, commensal
bacteria and viruses
The immune system has evolved distinct anti-bacterial or antiviral immune mechanisms
that enable efficient and targeted responses tailored to each particular class of pathogen
(Cousens et al., 1999; Curtis and Way, 2009; Kumar et al., 2009). Therefore, it was
surprising that ABX-mediated disruption of commensal bacterial communities resulted in
an impaired antiviral immune response. The results presented in this thesis suggest a
conserved element of the innate immune system that utilizes tonic signaling from
commensal bacteria to calibrate the activation threshold required to respond to viral
infections. It has been previously demonstrated that components classically considered
part of the anti-bacterial response, such as the LPS/TLR4 signaling axis, can also trigger
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transcription of an antiviral gene program (Amit et al., 2009; Doyle et al., 2002). Further,
the bacterial colonization with Wolbachia in Drosphilia flies confers protection against
viral infections (Teixeira et al., 2008). Conversely, latent viral infections can basally
activate innate immunity rendering latently-infected hosts less susceptible to bacterial
challenge (Barton et al., 2007). These studies provide novel insights into how distinct
microbial sensing and response pathways are interwoven and provide evidence for
critical cross-regulation of antiviral immunity by bacterial communities.
Commensal bacteria-driven gene transcription of immune response genes in the
steady-state may be a universal mechanism to modulate the pathogen response profile
of immune and non-immune cell types. Hooper and colleagues first reported marked
differences in immune response gene expression in cells derived from the intestinal
epithelium (Hooper et al., 2001). The findings reported in Chapter 4 of thesis
demonstrate a role for commensal bacteria-driven gene transcription in cells outside the
gastrointestinal tract. Disruption of microbial signaling by commensal bacteria reduced
expression of antiviral defense genes in macrophages (Chapter 4; Figure 28). Further,
while analysis of macrophages in this thesis did not reveal changes in expression of
inflammasome related genes, Ichinohe and colleagues reported decreased expression
of inflammasome components in the lung of ABX-treated mice both in the steady-state
and following influenza virus infection (Ichinohe et al., 2011). These data suggest that
gene expression of the inflammasome in a non-macrophage resident lung cell
population may be mediated by commensal bacteria-derived signals. Collectively, these
studies support a model where commensal bacteria-derived signals can coordinately
influence the gene expression profile of multiple cell types thereby modulating the
immune system at homeostasis and in an infection setting.
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5.3 Mediators of constitutive type I IFN expression
Genome-wide transcriptional profiling of macrophages isolated from naïve CNV or ABXtreated mice revealed an altered gene expression profile following disruption of
commensal bacterial communities by ABX treatment. Examination of the top 50
relatively upregulated genes in macrophages isolated from CNV mice compared to ABXtreated mice revealed increased basal expression of several interferon response genes
(IRGs) that regulate or are regulated by the IFN signaling pathway (Table 2). Analysis of
the gene expression microarray data with Ingenuity Pathways software and GSEA
independently identified the interferon response as one of the main pathways disrupted
in macrophages isolated from ABX-treated mice. Functional assays confirmed
macrophages isolated from ABX-treated exhibited a defect in responding to IFN
stimulation and, in turn, an impaired ability to control viral replication. Basal transcription
of IRGs is thought to be maintained by constitutive type I IFN expression (Gough et al.,
2012). It has long been appreciated that even in the absence of viral infection, low-level
expression of type I IFNs can be detected in multiple tissues of mice and humans (Bocci,
1980; Tovey et al., 1987; Yaar et al., 1986). Constitutive IFN expression is important in
maintaining a state of antiviral readiness as ablation of constitutive IFN signaling by
using anti-interferon-α/β neutralizing antibodies or genetic deletion of the IFN-α/β
receptor results in decreased expression of IRGs such as STAT1, STAT2 and IRF7
(Gough et al., 2010; Hata et al., 2001). Further, macrophages isolated from mice treated
with anti-IFN neutralizing antibodies exhibited delayed induction of antiviral defense
mechanisms and impaired control of viral replication, demonstrating the physiological
relevance of constitutive IFN in priming immune cells to be ready to respond to viruses
(Belardelli et al., 1984). Currently, the origins of the stimuli for constitutive IFN
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expression are not known, although the observation that macrophages isolated from
C3H/HeJ mice, which have defective TLR4 signaling, do not express constitutive IFN
and have impaired phagocytic and antiviral function has lead to speculation that
commensal bacteria-derived signals may be important regulators of constitutive IFN
expression (Gough et al., 2012; Musso et al., 2011; Vogel and Fertsch, 1984).
While type I IFN production following viral infection is critically dependent on
IRF3/IRF7, these two transcription factors do not have a role in mediating constitutive
IFN expression (Hata et al., 2001; Sato et al., 2000). Rather, relA and c-Jun, subunits of
the NFκB and AP-1 transcription factor complex respectively, bind to distinct positive
regulatory domains of the Ifnb promoter and are essential for constitutive IFN expression
(Balachandran and Beg, 2011; Gough et al., 2012; Maniatis et al., 1998). Loss of
constitutive IFN expression in c-Jun-deficient fibroblasts result in decreased STAT1
protein levels and impaired responsiveness to IFN-γ stimulation (Gough et al., 2012).
Meanwhile, reduced expression of Ifnb mRNA in rela-/- MEFs correlated with decreased
expression of genes involved in viral detection (MDA5 and RIG-I) and propagation of the
IFN signaling pathway (STAT1, STAT2 and IRF7) (Basagoudanavar et al., 2011).
Notably, these same genes were also decreased in macrophages isolated from ABXtreated mice (Chapter 4, Figure 28). Further, similar to macrophages isolated from ABXtreated mice, following viral infection rela-/- cells exhibited a delayed induction of antiviral
defense genes and impaired control of viral replication (Chapter 4, Figures 31-32)
(Basagoudanavar et al., 2011). In a study by Basagoudanavar et al., constitutive IFN
expression was induced by continuous degradation of NFκB by IKK-β, releasing relA to
translocate to the nucleus and bind to the Ifnb promoter region (Basagoudanavar et al.,
2011). At present, the source of IKK-β activation leading to NFκB degradation is unclear;
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however, it has been reported that commensal bacteria-mediated activation of NFκB in
intestinal epithelial cells is important in maintaining intestinal homeostasis and initiating a
protective immune response following intestinal parasitic infection (Nenci et al., 2007;
Zaph et al., 2007). Thus, it is tempting to speculate that commensal bacteria, perhaps
through the LPS/TLR4 signaling axis, regulate constitutive IFN expression via NFκB
degradation and relA-induced transcription. Consistent with this, LPS signaling can lead
induction to of Ifnb as well as transcription of IRGs, such as Mx1, Irf7, and Ifi1 in a NFκB
dependent manner (Doyle et al., 2002). In this scenario, two potential models arise: i.)
commensal bacteria-derived signals circulate through the host and directly induce
constitutive IFN expression in innate immune cells or ii.) commensal bacteria-derived
signaling is localized to the intestinal environment and stimulates constitutive IFN
production by intestinal epithelial and/or intestinal immune cells. Constitutive IFN is then
released into the circulation and can stimulate basal transcription of IFN response genes
in peripheral immune and non-immune cells. Cell lineage-specific deletion of type I IFNs
or the molecular machinery leading to constitutive IFN expression in mice will give
valuable insight how commensal bacterial communities regulate IFN responses (Figure
37).

5.4 Regulation of constitutive type I IFN expression
Type I IFN expression can initiate a potent antiviral immune response. However,
uncontrolled expression of IFNs can also be detrimental to the host and has been linked
to autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis,
and scleroderma (Banchereau and Pascual, 2006; Hooks et al., 1979). Therefore, the
host must tightly regulate constitutive IFN expression to promote rapid responses to viral
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pathogens while limiting destructive host tissue damage. Constitutive IFN expression is
regulated in part by the transcription factor IRF2, an IFN-inducible gene that is
constitutively expressed in multiple tissues (Senger et al., 2000; Taniguchi et al., 2001).
IRF2 is believed to repress Ifnb transcription by competitively binding to the positive
regulatory domain of the Ifnb promoter and via its transcriptional repression domain in
the carboxyl terminal region (Taniguchi et al., 2001; Yamamoto et al., 1994). Therefore,
basal IFN production may induce transcription of its own negative regulator, IRF2,
creating a negative feedback loop to limit constitutive IFN expression. Genetic deletion
of IRF2 in mice leads to increased baseline expression of IRGs and spontaneous
induction of a psoriasis-like skin disease (Arakura et al., 2007; Hida et al., 2000)
indicating unchecked regulation of constitutive IFN expression in these mice. Onset of
the autoimmune skin disease could be ameliorated by backcrossing the IRF2-/- mice onto
a IFN signaling deficient background (IFNAR-/- or IRF9-/-) demonstrating that the disease
pathogenesis was type I IFN-dependent (Hida et al., 2000). Thus transcription of
constitutive IFN expression is continuously regulated by repressors (IRF2) and activators
(relA) binding to the promoter region, possibly preventing histone deacetylation of the
chromatin and maintaining the gene locus in an open formation (Figure 38). Dynamic
transcriptional regulation, as discussed in Chapter 4, could keep the gene locus in an
active state that can be quickly accessed upon detection of viral infection by PRRs and
phosphorylation of IRF3/7, both primary inducers of type I IFN expression. The removal
of commensal bacteria-derived signals could reduce activator and repressor signals for
constitutive IFN expression and leave the Ifn gene in a closed dormant state resulting in
decreased expression of IRGs in cells in the steady-state as observed in Chapter 4 with
macrophages from ABX-treated mice.
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In addition to IFN signaling, IRF2 expression can also be modulated by other
commensal bacteria-derived signals such as LPS (Marson et al., 2004), butyric acid (a
SCFA produced by degradation of dietary fibers by commensal bacteria) (Joseph et al.,
2004), and oxidized low density lipoprotein (oxLDL) (Marson et al., 2004), which has
been reported to be elevated in the serum of GF mice (Velagapudi et al., 2010).
Potential regulation of IRF2 expression by commensal bacteria via IFN-dependent or
independent mechanisms may result in shaping additional arms of the immune system.
For example, NK cells, whose cytotoxic activity can be augment by administration of
probiotics (Matsuzaki and Chin, 2000), exhibit impaired target cell killing following
stimulation with poly I:C or in a tumor rejection model in IRF2-/- mice (Lohoff et al., 2000).
Further, Irf2-/- mice exhibit a skewed type-2 inflammatory phenotype with elevated serum
IgE, increased basophils in the spleen and blood, and an expanded, basophil-dependent
CD4 TH2 cell population (Hida et al., 2005), attributes which are phenocopied in both
ABX-treated and GF mice (Hill et al., 2012). Notably, in agreement with these findings,
genetic polymorphisms in IRF2 and alteration in commensal bacterial communities have
each been associated with atopic dermatitis, a type 2 cytokine-mediated inflammatory
disease in human patients (Gao et al., 2011; Penders et al., 2007a). Cell-lineage specific
deletion of IRF2 and manipulation of commensal bacterial communities in these murine
models will be needed to better understand the possible connection between
commensal bacteria, IRF2 expression, and immune cell homeostasis. Combined these
findings suggest that commensal bacteria-derived signals may differentially modulate
distinct immune cell populations and highlight the importance of understanding how
commensal bacteria-derived signals mediate immune regulation and via what cell type
these signals are eliciting their immunomodulatory effect.
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5.5 Therapeutic potential of commensal bacterial communities
Modulating commensal bacterial communities has great therapeutic potential. Clinical
probiotic treatment can ameliorate intestinal inflammatory diseases (Mimura et al., 2004;
Sartor, 2004), and success of bacteriotherapy in cases of viral gastroenteritis
demonstrates the potential use of probiotics as a treatment strategy to combat viral
infection (Fang et al., 2009; Isolauri et al., 1994; Majamaa et al., 1995; Szajewska and
Mrukowicz, 2005). Further, prophylactic probiotic administration can limit the duration
and severity of respiratory viral infections and correlates with increased cell-mediated
immune responses in human subjects, suggesting that the beneficial effects of probiotics
on antiviral immunity are not limited to the gastrointestinal tract (de Vrese et al., 2006;
Pregliasco et al., 2008). Conversely, the data presented in this thesis suggest that
removing or limiting exposure to commensal bacterial communities, such as in
populations receiving long-term antibiotic treatment, may increase an individual’s
predisposition to viral infection. This interpretation should be tempered, however, by
findings demonstrating how enteric viruses use commensal bacteria to their benefit to
improve viral infectivity and limit the host’s immune response (Kane et al., 2011; Kuss et
al., 2011). These two studies highlight the need to further characterize the specific
bacterial products that can mediate susceptibility to infection.
Despite many recent advances in defining the diverse microbiome in humans and
animal models (Peterson et al., 2009), only a few commensal species or microbial
products that elicit an immunomodulatory effect have been defined (Reading and
Kasper, 2011). Thus, it is currently unclear which commensal species or specific
microbial products are associated with the beneficial clinical observations described
above or the impact on antiviral immunity described in this thesis. The experiments
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presented in this thesis, as well as numerous other published reports, have used a broad
spectrum antibiotic cocktail designed to target all classes of bacteria (Gram positive,
Gram negative; Aerobes, Anaerobes) to address how commensal bacteria modulate the
immune system. This strategy indiscriminately, albeit successfully, eliminates signals
derived from multiple commensal bacteria and therefore makes identification of specific
species or commensal bacteria-derived products that elicit observed immunomodulatory
effects difficult. It will be important to determine which bacterial products are
immunomodulatory and to investigate the distinct signaling pathways these products
stimulate. Such studies should allow for the development of novel strategies to
therapeutically administer specific commensal bacteria or commensal bacteria-derived
products and selectively manipulate host immunity.

5.6 Alternative mechanisms of immune regulation by manipulating
commensal bacterial communities
The most direct interpretation of the data presented in this thesis is that in the steadystate, commensal bacteria provide tonic signals that regulate the activation threshold of
the innate immune system required for optimal antiviral immune responses. However,
disruption of commensal bacterial communities may be indirectly impairing antiviral
immunity via alteration of the host viral microbiome. Disruptions of intestinal commensal
bacterial communities may also alter the bacteriophage population, endogenous viruses
residing in intestinal bacteria that substantially contribute to the pool of genes that
comprise the intestinal metagenome (Letarov and Kulikov, 2009). It is possible that
depletion of commensal bacteria could be indirectly leading to immune dysregulation via
loss of a bacterial population that harbors viruses capable of interacting with host
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immune cells and modulating immune responses. Currently, characterization of the
human microvirome is still in its infancy and the technologic tools needed to manipulate
the microvirome to probe the impact of these endogenous viruses on health and disease
have yet to be developed (Reyes et al., 2010). Thus the role of the intestinal
microvirome in modulating immune response remains largely unexplored.
Alternatively, loss of commensal bacteria may influence host immune responses by
disrupting the breakdown of metabolites that have immunoregulatory properties.
Intestinal commensal bacteria have a crucial role in the metabolic breakdown of food
products and loss of commensal bacterial species alters nutrients available to be
absorbed by the host (Velagapudi et al., 2010). Some food products are already known
to modulate immune cell homeostasis. For example, vitamin A via its metabolite, retinoic
acid, can shape immune cell differentiation and mediate tolerance and immunity in the
gastrointestinal tract (Hall et al., 2011). While vitamin A conversion is not a process
governed by commensal bacteria, it is possible to envision a scenario where loss of
commensal bacterial species crucial in the breakdown and release of a metabolite with
immunomodulatory function would result in shifts in immune homeostasis. Indeed, short
chain fatty acids (SCFA), metabolic byproducts of fermentation of dietary fibers by
commensal bacteria, can bind to the G-protein-coupled receptor 43 that is expressed on
immune cells (Brown et al., 2003; Le Poul et al., 2003) and can limit inflammatory
responses (Maslowski et al., 2009). GF mice, which cannot produce SCFA due to loss of
commensal

microbes

(Hoverstad

and

Midtvedt,

1986),

do

not

have

this

immunoregulatory mechanism and are more susceptible to chemically-induced intestinal
inflammation (Maslowski et al., 2009). Further studies are needed to understand how
disruption commensal bacterial communities are interwoven with changes in metabolism
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in order to tease apart the precise mechanisms of action used by commensal bacterial
communities to influence the immune system.

5.7 Concluding remarks
This thesis demonstrates the importance of commensal bacteria-derived signals in
regulating antiviral immunity. In the absence of commensal bacteria-derived signals, the
immune machinery for antiviral defense, while functionally intact, may lay dormant,
waiting for activating signals to initiate it into action. This passive state can prove to be
dangerous to the host if the invading pathogen can establish a replicative advantage
before the host organism’s immune system is activated to respond. Evolutionarily
speaking, it would be beneficial for an organism to have its immune system in a state of
constitutive readiness, producing anti-pathogen factors to prophylactically prevent
infection and ensure the organism’s fitness for survival and reproduction. Two obstacles
lie in the way of this strategy. First, continuous expression of immune response genes
would exact a substantial metabolic burden on the organism and require diversion of a
large amount of energy resources to sustain. Second, a prolonged fully activated
immune response could only be tolerated for a certain period of time before eventually
resulting in pathologic damage to the host’s tissues and organs. The immune system
may have evolved to simultaneously overcome both of these obstacles by engaging with
surrounding commensal bacterial communities and utilizing commensal bacteria-derived
signals as an immuno-rheostat to calibrate itself for efficient and rapid responses to
potential dangers while limiting energy consumption and exposure to potentially harmful
immune responses. Using this kind calibration mechanism would give an organism a
distinct evolutionary survival advantage by establishing basal protection against a threat
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that has yet to be encountered and thus cannot be predicted, in terms of type, timing and
location. Therefore, the immune system may have evolved to incorporate signals from
commensal bacterial communities as part of its repertoire of host defense mechanisms,
as important to host defense as any other arm of the immune system.
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Figure 36. Commensal bacteria-derived signals calibrate the activation threshold
of macrophages required for a rapid and robust antiviral immune response.

Figure 36. (A) Commensal bacteria‐derived signals tonically stimulate macrophages and
initiate basal transcription of IFN response genes (IRG). (B) Decreased commensal bacteria‐
derived signaling results in diminished expression of IRGs. (A,B) Upon viral infection,
macrophages conditioned by commensal bacteria‐derived signals induce a rapid and robust
response, while macrophages that have been deprived of tonic stimulation from commensal
bacteria exhibit a delayed and impaired antiviral response.
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Table 2. Top 50 relatively increased genes in CNV macrophages compared to ABX
macrophages.
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Table 2. Top 50 genes that are expressed at relatively elevated levels in macrophages
isolated from naïve CNV mice compared to macrophages isolated from naïve ABX‐treated
mice. Bold highlighted genes denote genes that are related to the IFN signaling pathway.
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Figure 37. Potential models for commensal bacteria-driven constitutive type I IFN
expression.

Figure 37. (1) Commensal bacteria may signaling via IECs or resident intestinal immune cells
to induce constitutive type I IFN expression that can be secreted into circulation and
stimulate peripheral immune cells. (2) Alternatively, Commensal bacteria‐derived products
could translocate from the intestine and directly stimulate innate immune cells to produce
low levels of constitutive type I IFN that induce basal transcription of IFN response genes
(IRG).
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Figure 38. Dynamic versus dormant transcriptional regulation of constitutive type
I IFN expression.

Figure 38. Expression of constitutive type I IFN is regulated by transcription factors relA
(promoter) and IRF2 (repressor). Constitutive degradation of NFκB releases the relA subunit ,
which translocates into the nucleus. relA binds to the Ifnβ promoter region and induces
expression of type I IFN. Type I IFN signaling leads to the formation of the IFN‐stimulated
gene factor 3 transcription factor complex (ISGF3), which initiates transcription of IRGs
including IRF2, a transcriptional repressor of type I IFN. (A) Presence of both promoting and
repressing factors can maintain genes in a state of dynamic transcriptional regulation and
may allow for faster or more efficient transcriptional induction upon activation by a primary
inducer (Viral PAMPs) compared to a (B) dormant or inactive state. Commensal bacterial‐
derived signals may influence constitutive type I IFN expression by regulating either
promoter or repressor activation.
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